[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1899
1. Silva J, Cachulo Mdo C, Leitão-Marques A: Secondary hypertension to rare adrenal gland tumor. Arq Bras Cardiol; 2010 Dec;95(6):e144-7
MedlinePlus Health Information. consumer health - High Blood Pressure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secondary hypertension to rare adrenal gland tumor.
  • The ganglioneuroma is a tumor of the sympathetic nervous system and may be associated with hypersecretion of vasoactive substances responsible for various symptoms and signs such as hypertension.
  • The authors report a case of ganglioneuroma and a literature review, focusing on the most important aspects of diagnosis and therapy.
  • The patient had recurrent symptomatic hypertensive crises, having performed an imaging study that found a nodule in the right adrenal gland.
  • As neuroblastic tumors are radiologically undistinguishable, the patient underwent excision, confirming the diagnosis by pathology analysis.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Ganglioneuroma / complications. Hypertension / etiology

  • Genetic Alliance. consumer health - Adrenal Hypertension.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21271185.001).
  • [ISSN] 1678-4170
  • [Journal-full-title] Arquivos brasileiros de cardiologia
  • [ISO-abbreviation] Arq. Bras. Cardiol.
  • [Language] eng; por; spa
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  •  go-up   go-down


2. Hoshiyama F, Hosokawa Y, Kumamoto H, Hayashi Y, Fujimoto K, Hirao Y: [Choriocarcinoma presenting as a spontaneous rupture of an adrenal metastasis: a case report]. Hinyokika Kiyo; 2008 Apr;54(4):281-4
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Choriocarcinoma presenting as a spontaneous rupture of an adrenal metastasis: a case report].
  • An abdominal enhanced computed tomography (CT) revealed retroperitoneal hemorrhage, leading to life-threatening, and multiple tumors in the liver.
  • These findings strongly indicated a spontaneous rupture of adrenal tumor.
  • An examination during surgery showed a rupture of adrenal tumor.
  • En bloc resection of adrenal gland, tumor, and the kidney was performed.
  • Pathological finding revealed the adrenal tumor was choriocarcinoma.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Choriocarcinoma / pathology. Uterine Neoplasms / pathology

  • Genetic Alliance. consumer health - Choriocarcinoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18516921.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


3. Sawazaki H, Segawa T, Yoshida K, Kawahara T, Inoue T, Soda T, Kamba T, Yoshimura K, Takahashi T, Nakamura E, Nishiyama H, Ito N, Kamoto T, Ogawa O: [Hemorrhagic adrenocortical adenoma with myelolipoma: a case report]. Hinyokika Kiyo; 2006 Oct;52(10):785-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on abdominal computed tomography, magnetic resonance imaging and blood tests, preoperative diagnosis was a sarcoma of renal capsule origin.
  • En bloc resection of adrenal gland, tumor, and the kidney with lymph node dissection was performed.
  • [MeSH-major] Adrenal Cortex Neoplasms / complications. Adrenal Gland Neoplasms / etiology. Adrenocortical Adenoma / complications. Myelolipoma / etiology. Neoplasms, Multiple Primary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131868.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


Advertisement
4. [Adrenal gland tumor removed from a dog via video surgery]. Tijdschr Diergeneeskd; 2007 Apr 15;132(8):308
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal gland tumor removed from a dog via video surgery].
  • [Transliterated title] Bijniertumor hond via kijkoperatie verwijderd.
  • [MeSH-major] Adrenal Gland Neoplasms / veterinary. Dog Diseases / surgery. Video-Assisted Surgery / veterinary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Tijdschr Diergeneeskd. 2007 May 15;132(10):407 [17580402.001]
  • (PMID = 17489377.001).
  • [ISSN] 0040-7453
  • [Journal-full-title] Tijdschrift voor diergeneeskunde
  • [ISO-abbreviation] Tijdschr Diergeneeskd
  • [Language] dut
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


5. Miwa Y, Uchida K, Nakayama H, Asaki N: Neuroblastoma of the adrenal gland in a ferret. J Vet Med Sci; 2010 Sep;72(9):1229-32
MedlinePlus Health Information. consumer health - Neuroblastoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neuroblastoma of the adrenal gland in a ferret.
  • The excised mass was histologically diagnosed as a medullary tumor of the adrenal gland, and some neoplastic cells were beta III-tubulin-, doublecortin- and neurofilament-positive.
  • Based on these findings, the tumor was considered to be a neuroblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20431253.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


6. Wang TS, Ocal IT, Salem RR, Elefteriades J, Sosa JA: Leiomyosarcoma of the adrenal vein: a novel approach to surgical resection. World J Surg Oncol; 2007;5:109
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of the adrenal vein: a novel approach to surgical resection.
  • Leiomyosarcomas arising from the adrenal vein are rare malignancies associated with delayed diagnosis and poor prognosis.
  • CASE PRESENTATION: This is a 64-year old woman who presented with a 13 x 6.5 x 6.6 cm heterogeneous mass arising in the region of the right adrenal gland and extending into the inferior vena cava (IVC) and the right atrium.
  • Biochemical evaluation excluded a functional tumor of the adrenal gland, and multiple tumor markers were negative.
  • We present the novel use of deep hypothermic circulatory arrest (DHCA) in the resection of an adrenal vein leiomyosarcoma extending into the right atrium.
  • The patient remains free of disease ten months after surgery.
  • DHCA afforded a bloodless operative field for optimal resection of disease from within the IVC.
  • CONCLUSION: The diagnosis of leiomyosarcomas of the adrenal vein is one of exclusion and involves preoperative radiological imaging and biochemical evaluation to exclude other functional tumors of the adrenal gland.
  • [MeSH-major] Adrenal Glands / blood supply. Leiomyosarcoma / surgery. Neoplasm Invasiveness / pathology. Vascular Neoplasms / surgery. Vena Cava, Inferior

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1999 Mar 1;85(5):1077-83 [10091791.001]
  • [Cites] Arch Pathol Lab Med. 1997 Aug;121(8):834-8 [9278611.001]
  • [Cites] Ann Surg. 2006 Aug;244(2):289-95 [16858193.001]
  • [Cites] Int J Urol. 2002 Jan;9(1):54-6 [11972651.001]
  • [Cites] Pathology. 2003 Feb;35(1):47-9 [12701684.001]
  • [Cites] J Am Coll Surg. 2003 Oct;197(4):575-9 [14522326.001]
  • [Cites] Int J Clin Oncol. 2004 Jun;9(3):189-92 [15221604.001]
  • [Cites] J Surg Oncol. 1981;16(2):145-8 [7464153.001]
  • [Cites] J Urol. 1984 Jan;131(1):103-7 [6690724.001]
  • [Cites] Ann Thorac Surg. 1989 Sep;48(3):421-2 [2774730.001]
  • [Cites] J Urol. 1990 Sep;144(3):735-9 [2388341.001]
  • [Cites] Am J Surg Pathol. 1991 Sep;15(9):899-905 [1951846.001]
  • [Cites] J Thorac Cardiovasc Surg. 1993 Jul;106(1):19-28; discussion 28-31 [8321002.001]
  • [Cites] Arch Pathol Lab Med. 1995 Dec;119(12):1164-7 [7503667.001]
  • [Cites] Anticancer Res. 1996 Sep-Oct;16(5B):3201-5 [8920790.001]
  • [Cites] Am Surg. 2005 Jun;71(6):497-501 [16044929.001]
  • (PMID = 17910774.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2117013
  •  go-up   go-down


7. Miwa Y, Kurosawa A, Ogawa H, Nakayama H, Sasai H, Sasaki N: Neoplasitic diseases in ferrets in Japan: a questionnaire study for 2000 to 2005. J Vet Med Sci; 2009 Apr;71(4):397-402
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to collect epidemiological data on neoplasms in pet ferrets in Japan.
  • Completed questionnaires were returned from 29 practices, and 945 neoplasms met the criteria for inclusion in the study.
  • Neoplasms were found in every organ system except the respiratory system; the endocrine (418; 44.2%), integumentary (196; 20.7%) and hemolymphatic (184; 19.5%) systems were most commonly affected.
  • The most common tumor types were pancreatic islet cell tumor (211: 22.3%), adrenal gland tumor (207; 21.9%) and lymphoma (152; 16.1%).
  • Tumor incidence was highest in ferrets between 4 and 6 years of age.
  • Most Japanese pet ferrets are imported from North America, and their husbandry including diets is similar to that in North America, which may explain the similar tendencies in the incidence of neoplasms in this study and those of findings in North America.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19420840.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


8. Diachenko VV, Nichitaĭlo ME, Kvacheniuk AN, Gul'ko ON: [Laparoscopic interventions for adrenal gland tumor]. Klin Khir; 2006 Jan;(1):49-52
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic interventions for adrenal gland tumor].
  • Clinical course, hormonal characteristics and efficacy of rehabilitation were studied by the authors in 12 patients with suprarenal gland tumor, operated, using minimally invasive endoscopic intervention--laparoscopic adrenalectomy (LA).
  • Efficacy, indications, contraindications, role of LA in the treatment of surgical adrenal diseases were analyzed.
  • LA is characterized by invasiveness and traumaticity, adequate radicalism, quick rehabilitation, and good remote results.
  • LA is indicated for the treatment of majority of hyperplastic and tumoral diseases of suprarenal glands: it is possible to operate 60% of patients with surgical diseases of suprarenal glands using endoscopic technology.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16719074.001).
  • [ISSN] 0023-2130
  • [Journal-full-title] Klinichna khirurhiia
  • [ISO-abbreviation] Klin Khir
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Ukraine
  •  go-up   go-down


9. Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S: Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol; 2006 Mar;17(3):573-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant hypertension during cryoablation of an adrenal gland tumor.
  • The authors report a case of hypertensive crisis during cryoablation of an adrenal metastasis.
  • Based on their observations, the authors suggest that it may be prudent to pretreat this patient population with alpha-adrenergic blocking medications (eg, phenoxybenzamine), as is typically done for patients with neuroendocrine tumors such as pheochromocytoma.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Cryosurgery / adverse effects. Hypertension, Malignant / etiology

  • Genetic Alliance. consumer health - Adrenal Hypertension.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Vasc Interv Radiol. 2006 Aug;17(8):1367-8 [16923989.001]
  • (PMID = 16567684.001).
  • [ISSN] 1051-0443
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Karmisholt J: [Adrenal gland tumor biopsy]. Ugeskr Laeger; 2009 Mar 16;171(12):1015; author reply 1015
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal gland tumor biopsy].
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Humans. Pheochromocytoma / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Ugeskr Laeger. 2009 Jan 26;171(5):306-8 [19176156.001]
  • (PMID = 19306484.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Comment; Letter
  • [Publication-country] Denmark
  •  go-up   go-down


11. Rose SA, Kyles AE, Labelle P, Pypendop BH, Mattu JS, Foreman O, Rodriguez CO Jr, Nelson RW: Adrenalectomy and caval thrombectomy in a cat with primary hyperaldosteronism. J Am Anim Hosp Assoc; 2007 Jul-Aug;43(4):209-14
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 13-year-old, castrated male, domestic longhaired cat was diagnosed with primary hyperaldosteronism from an adrenal gland tumor and a thrombus in the caudal vena cava.
  • [MeSH-major] Adrenal Gland Neoplasms / veterinary. Adrenalectomy / veterinary. Cat Diseases / surgery. Hyperaldosteronism / veterinary. Thrombectomy / veterinary

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17615401.001).
  • [ISSN] 1547-3317
  • [Journal-full-title] Journal of the American Animal Hospital Association
  • [ISO-abbreviation] J Am Anim Hosp Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Behrend EN, Weigand CM, Whitley EM, Refsal KR, Young DW, Kemppainen RJ: Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog. J Am Vet Med Assoc; 2005 May 15;226(10):1662-6, 1659
Hazardous Substances Data Bank. MITOTANE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog.
  • An adrenal gland tumor was visualized via ultrasonography and computed tomography.
  • Excess adrenal secretion of corticosterone was hypothesized to be the cause of the signs of glucocorticoid excess.
  • Treatment with mitotane was instituted and successful for a period of 4-months until the dog was euthanatized for neurologic problems that were most likely unrelated to endocrine disease.
  • [MeSH-major] Adrenal Cortex Neoplasms / veterinary. Aldosterone / secretion. Antineoplastic Agents, Hormonal / therapeutic use. Corticosterone / secretion. Dog Diseases / diagnosis. Mitotane / therapeutic use

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15906564.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 4964P6T9RB / Aldosterone; 78E4J5IB5J / Mitotane; W980KJ009P / Corticosterone
  •  go-up   go-down


13. Komissarenko IV, Rybakov SI, Kvacheniuk AN, Lazar' SI, Fedorova TI, Kovalenko AE, Mel'nik ND, Negrienko KV: [Using magnetic-resonance tomography in differential diagnosis of the adrenal glands malignant tumors]. Klin Khir; 2005 Oct;(10):47-50
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Using magnetic-resonance tomography in differential diagnosis of the adrenal glands malignant tumors].
  • Possibilities of application of magnet-resonance tomography (MRT) for differential diagnosis of the adrenal glands tumors were studied up.
  • MRT was conducted to 39 patients with adrenal glands tumors, including 22 - with malignant adrenal gland tumor, 17 - with benign tumor of adrenal gland.
  • MRT constitutes the most effective method of topic diagnosis of the adrenal glands tumor, owes multipurpose possibilities, do not deliver radiation load, permits to visualize the vessels without the contrast media usage.
  • The tumor diameter more than 10,1 cm, irregular form, illegible edges, uneven contours, presence of lymphadenopathy, regional or remote metastases constitutes diagnostic criterions of the adrenal glands malignant tumors.
  • The intensity of MRT signal could not be used for differential diagnosis of malignant and benign tumors of adrenal glands.

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16509086.001).
  • [ISSN] 0023-2130
  • [Journal-full-title] Klinichna khirurhiia
  • [ISO-abbreviation] Klin Khir
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Ukraine
  •  go-up   go-down


14. Wosnitzer M, Lee DJ, Hirsch AJ, McKiernan JM: Predictors of renal function in nephron sparing surgery for renal cell carcinoma in solitary kidneys. J Clin Oncol; 2009 May 20;27(15_suppl):e16045

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictors of renal function in nephron sparing surgery for renal cell carcinoma in solitary kidneys.
  • : e16045 Background: Partial nephrectomy (PN) is an effective option for the treatment of renal cell carcinoma (RCC) in patients who need to preserve renal function.
  • We assessed the outcomes after PN, and evaluated predictors of post-operative renal function.
  • Glomerular filtration rate (GFR) was estimated with the Modification of Diet in Renal Disease (MDRD) equation.
  • Severe chronic kidney disease (CKD) and renal failure were defined as GFR of 15-30 cc/min/1.73m2 and GFR<15, respectively.
  • The mean estimated blood loss was 465cc, the mean tumor diameter was 3.9cm, and 6 (17%) of the patients had a positive surgical margin.
  • Recurrence occurred in the kidneys of 4 patients, lung in 3 patients, bone in 3 patients, and the ipsilateral adrenal gland in one patient.
  • Preoperative GFR (HR=1.01, p<0.01) and the volume of kidney removed (HR=0.93, p=0.01) were associated with severe CKD and renal failure on a univariate Cox regression analysis, but were not independent predictors after adjusting for age, race, tumor stage and grade.
  • Preoperative GFR, volume removed, age, tumor stage or grade were not independent predictors of RCC recurrence.
  • Nephron sparing surgery for the treatment of RCC is feasible with acceptable morbidity and renal function outcome.
  • The volume of renal parenchyma removed and the preoperative GFR are associated with renal function loss several months after surgery, and may be useful in predicting long-term renal function.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963019.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Zardi EM, Santini D, Vincenzi B, Galati G, Tonini G, Zobel BB, Afeltra A: Surgical complications after resection of adrenal carcinoma. J Exp Clin Cancer Res; 2006 Sep;25(3):449-51
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical complications after resection of adrenal carcinoma.
  • Sonographic and tomographic examinations showed the presence of a large adrenal gland tumor and the promptly performed adrenalectomy and splenectomy proved that the lesion was an adrenal gland carcinoma infiltrating the spleen.
  • One month after surgical treatment, the patient's general condition dramatically worsened due to development of perirenal abscess and renal infarction; finally, the patient died.
  • [MeSH-major] Adrenal Cortex Neoplasms / surgery. Adrenocortical Carcinoma / surgery. Postoperative Complications / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17167987.001).
  • [ISSN] 0392-9078
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


16. Niinobu T, Yamashita S, Nakagawa S, Amano M, Higaki N, Hayashida H, Nakao A, Takiuchi H, Sakon M: [Laparoscopic adrenalectomy for the adrenal gland metastasis from hepatocellular carcinoma]. Gan To Kagaku Ryoho; 2006 Nov;33(12):1765-7
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic adrenalectomy for the adrenal gland metastasis from hepatocellular carcinoma].
  • A 4 x 3.5 cm neoplasm at the left adrenal was detected by CT inspection this time.
  • The diagnosis was a metastatic adrenal gland tumor from HCC.
  • Pathologial diagnosis was a metastatic adrenal gland tumor from moderately differentiated hepatocellular carcinoma.
  • When observing the adaptation standard strictly to the high-risk case, it was thought that the metastatic tumor extraction under laparoscopic surgery could become a low stress cure in consideration of QOL being useful as a local treatment for cancer.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Carcinoma, Hepatocellular / pathology. Laparoscopy. Liver Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17212101.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


17. Millard RP, Pickens EH, Wells KL: Excessive production of sex hormones in a cat with an adrenocortical tumor. J Am Vet Med Assoc; 2009 Feb 15;234(4):505-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Excessive production of sex hormones in a cat with an adrenocortical tumor.
  • Abdominal ultrasonography revealed a mass in the region of the right adrenal gland.
  • Results of adrenal hormonal analyses revealed considerable increases in serum concentrations of androstenedione and testosterone.
  • TREATMENT AND OUTCOME: A mass associated with the right adrenal gland was found during exploratory laparotomy.
  • Adrenalectomy of the right adrenal gland was performed, and histologic evaluation of the mass revealed an adrenocortical adenoma.
  • CLINICAL RELEVANCE: Adrenal gland tumors can produce a variety of hormones other than cortisol.
  • An adrenal gland tumor should be considered in neutered cats with newly developed physical and behavioral changes of a sexual nature.
  • In the absence of debilitating conditions that are often associated with hyperadrenocorticism, cats undergoing adrenalectomy for an adrenal gland tumor that is producing sex hormones may have resolution of clinical signs and a good prognosis.
  • [MeSH-major] Adenocarcinoma / veterinary. Adrenal Cortex Neoplasms / veterinary. Adrenalectomy / veterinary. Androstenedione / blood. Cat Diseases / blood. Testosterone / blood

  • Hazardous Substances Data Bank. TESTOSTERONE .
  • Hazardous Substances Data Bank. ANDROSTENEDIONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19222361.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 3XMK78S47O / Testosterone; 409J2J96VR / Androstenedione
  •  go-up   go-down


18. Chang JW, Chou CL, Huang SF, Wang HM, Hsieh JJ, Hsu T, Cheung YC: Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer. Lung Cancer; 2007 Dec;58(3):414-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor progressed in both lung and left adrenal gland.
  • Tumor progressed again 7 months later.
  • Complete regression of the lung tumor and partial response of the left adrenal gland mass was achieved.
  • Nine months later, the left lower lobe lung tumor and left adrenal gland tumor progressed.
  • He remained on erlotinib for a total of 18 months until the left adrenal gland tumor progressed.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / drug therapy. Carcinoma, Non-Small-Cell Lung / genetics. Drug Resistance, Neoplasm / drug effects. Lung Neoplasms / drug therapy. Lung Neoplasms / genetics. Quinazolines / therapeutic use. Receptor, Epidermal Growth Factor / genetics

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17618013.001).
  • [ISSN] 0169-5002
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Quinazolines; DA87705X9K / Erlotinib Hydrochloride; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


19. Tsoumakidou G, Buy X, Zickler P, Zupan M, Douchet MP, Gangi A: Life-threatening complication during percutaneous ablation of adrenal gland metastasis: Takotsubo syndrome. Cardiovasc Intervent Radiol; 2010 Jun;33(3):646-9
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Life-threatening complication during percutaneous ablation of adrenal gland metastasis: Takotsubo syndrome.
  • A rare life-threatening complication during percutaneous cryoablation of an adrenal gland metastasis from a lung carcinoma is reported.
  • These findings led to the diagnosis of Takotsubo cardiomyopathy left ventricular dysfunction syndrome.
  • This is the first case of Takotsubo cardiomyopathy occurring as a complication during percutaneous ablation of an adrenal gland tumor.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Cryosurgery / adverse effects. Lung Neoplasms / pathology. Takotsubo Cardiomyopathy / etiology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19495870.001).
  • [ISSN] 1432-086X
  • [Journal-full-title] Cardiovascular and interventional radiology
  • [ISO-abbreviation] Cardiovasc Intervent Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Smith M, Schulman FY: Subcutaneous neoplasms of the ventral abdomen with features of adrenocortical tumors in two ferrets. Vet Pathol; 2007 Nov;44(6):951-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subcutaneous neoplasms of the ventral abdomen with features of adrenocortical tumors in two ferrets.
  • In both cases, the neoplasms were composed of islands of polygonal cells separated by interlacing streams of spindloid cells reminiscent of ferret adrenocortical tumors with smooth muscle proliferation.
  • In one tumor, vesicular tubular mitochondria were found in polygonal cells.
  • The histologic, immunohistochemical, and ultrastructural findings are suggestive of adrenocortical tumors with smooth muscle proliferation, but cannot be differentiated from an ovarian gonadal stromal tumor.
  • Neither ferret had a clinically detected primary adrenal gland tumor or clinical signs of adrenal-associated endocrinopathy.
  • [MeSH-major] Adrenal Cortex Neoplasms / veterinary. Ferrets. Subcutaneous Tissue / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Vet Pathol. 2008 Jan;45(1):112
  • (PMID = 18039913.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Tanaka T, Sekimura A, Tanaka H, Tonegawa K, Ogawa K, Haneda H: [Gallbladder metastasis of large cell lung cancer]. Kyobu Geka; 2009 Nov;62(12):1069-72
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Computed tomography (CT) revealed gallbladder tumor and extended resection of the gallbladder was performed.
  • Pathological diagnosis was adenosquamous cell carcinoma After 1 year and 4 months later, left adrenal gland tumor was found by CT scan, and the surgery was conducted.
  • By reevaluation of pathology of the gallbladder, the tumor was found to have similar component of resected lung cancer, suggesting the possibility of the tumor to be metastatic.
  • [MeSH-major] Carcinoma, Large Cell / pathology. Gallbladder Neoplasms / secondary. Lung Neoplasms / pathology

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19894573.001).
  • [ISSN] 0021-5252
  • [Journal-full-title] Kyobu geka. The Japanese journal of thoracic surgery
  • [ISO-abbreviation] Kyobu Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


22. Herrera RN, Miotti JA, Fuentes CM, Robles SP, Amenabar JM, Luciardi HL: [Pheochromocytoma associated with von Recklinghausen neurofibromatosis]. Medicina (B Aires); 2007;67(5):475-7
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Feocromocitoma asociado a neurofibromatosis de von Recklinghausen.
  • A pheochromocytoma is an adrenal gland tumor that secretes epinephrine and norepinephrine hormones, and is responsible for regulating heart rate and blood pressure, among other functions.
  • Neurofibromatosis-1 (NF-1) an inherited "autosomal dominant" disorder is one of the most common genetic disorders, characterized by formation of neurofibromas (tumors involving nerve tissue) in the skin, subcutaneous tissue, cranial and spinal root nerves.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Neurofibromatosis 1 / complications. Pheochromocytoma / complications. Pheochromocytoma / diagnosis


23. Wagner RA, Piché CA, Jöchle W, Oliver JW: Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease. Am J Vet Res; 2005 May;66(5):910-4
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease.
  • OBJECTIVE: To evaluate the clinical and endocrine responses of ferrets with adrenocortical disease (ACD) to treatment with a slow-release implant of deslorelin acetate.
  • Plasma estradiol, androstenedione, and 17-hydroxyprogesterone concentrations were measured before and after treatment and at relapse of clinical signs; at that time, the adrenal glands were grossly or ultrasonographically measured and affected glands that were surgically removed were examined histologically.
  • In 5 ferrets, large palpable tumors developed within 2 months of clinical relapse; 3 of these ferrets were euthanatized because of adrenal gland tumor metastasis to the liver or tumor necrosis.
  • Deslorelin may not decrease adrenal tumor growth in some treated ferrets.
  • [MeSH-major] Adrenal Cortex Diseases / veterinary. Ferrets. Triptorelin Pamoate / administration & dosage. Triptorelin Pamoate / analogs & derivatives

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15934621.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drug Implants; 0 / Gonadal Steroid Hormones; 57773-63-4 / Triptorelin Pamoate; TKG3I66TVE / deslorelin
  •  go-up   go-down


24. Ramer JC, Benson KG, Morrisey JK, O'Brien RT, Paul-Murphy J: Effects of melatonin administration on the clinical course of adrenocortical disease in domestic ferrets. J Am Vet Med Assoc; 2006 Dec 1;229(11):1743-8
Hazardous Substances Data Bank. MELATONIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of melatonin administration on the clinical course of adrenocortical disease in domestic ferrets.
  • OBJECTIVE: To evaluate the effect of oral administration of melatonin on clinical signs, tumor size, and serum steroid hormone concentrations in ferrets with adrenocortical disease.
  • ANIMALS: 10 adult ferrets with clinical signs of adrenocortical disease (confirmed via serum steroid hormone concentration assessments).
  • At 4-month intervals, a complete physical examination; abdominal ultrasonographic examination (including adrenal gland measurement); CBC; serum biochemical analyses; and assessment of serum estradiol, androstenedione, and 17alpha-hydroxyprogesterone concentrations were performed.
  • RESULTS: Daily oral administration of melatonin greatly affected clinical signs of adrenocortical disease in ferrets; changes included hair regrowth, decreased pruritus, increased activity level and appetite, and decreased vulva or prostate size.
  • Mean width of the abnormally large adrenal glands was significantly increased after the 12-month treatment period.
  • CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that melatonin is a useful, easily administered, palliative treatment to decrease clinical signs associated with adrenocortical disease in ferrets, and positive effects of daily treatment were evident for at least an 8-month period.
  • Oral administration of melatonin did not decrease adrenal gland tumor growth in treated ferrets.
  • [MeSH-major] Adrenal Cortex Diseases / veterinary. Adrenal Cortex Neoplasms / veterinary. Ferrets. Melatonin / therapeutic use

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17144819.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gonadal Steroid Hormones; JL5DK93RCL / Melatonin
  •  go-up   go-down


25. Morio A, Ninomiya H, Sunada K, Tomioka K, Nakahara K: [A case of advanced non-small-cell lung cancer successfully treated with S-1 plus CBDCA after multiple chemotherapy]. Gan To Kagaku Ryoho; 2009 Sep;36(9):1533-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After the brain tumor extraction, CDDP (80 mg/m2) + GEM (1,000 mg/m2) were administered as first-line treatment, and the tumor response was PR (33.3% reduction rate), impaired liver function served to interrupt this regimen.
  • Other chemotherapy was then conducted in the order of GEM (1,000 mg/m2) + VNR (25 mg/m2), and CBDCA (AUC=5) + DOC(60 mg/m2), and the tumor response was NC.
  • After 3 courses of the treatment, the serum CEA level normalized, a chest CT detected the left lung tumor size reduction (66.7% reduction rate), and an abdominal CT detected disappearance of the left adrenal gland tumor.
  • Histopathological examination of the lung tumor showed viable adenocarcinoma cells.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lung Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19755827.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents; 0 / Carcinoembryonic Antigen; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; BG3F62OND5 / Carboplatin
  •  go-up   go-down


26. Ho YH, Yap WM, Chuah KL: Solitary fibrous tumor of the adrenal gland with unusual immunophenotype: a potential diagnostic problem and a brief review of endocrine organ solitary fibrous tumor. Endocr Pathol; 2010 Jun;21(2):125-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the adrenal gland with unusual immunophenotype: a potential diagnostic problem and a brief review of endocrine organ solitary fibrous tumor.
  • Solitary fibrous tumor was initially thought to be a pleura-based tumor.
  • Nonetheless, a primary involvement of the endocrine organs is rare, and in this report, we detail an instance where the tumor affected the adrenal gland of a 71-year-old Arab man.
  • On histology, besides the typical morphologic features seen in solitary fibrous tumor, the neoplasm also exhibited unusual features on immunohistochemistry such as positive staining for cytokeratin AE1/3 and calponin in conjunction with diffuse expression for S-100.
  • The genetic tests for t(X:18) as seen in synovial sarcoma were negative, and the overall histological appearance favored a diagnosis of solitary fibrous tumor.
  • To the best of our knowledge, this report represents the fifth case of a solitary fibrous tumor primarily occurring in the adrenal gland.
  • The differential diagnoses of this neoplasm in our case and a brief summary of solitary fibrous tumor primarily involving the various endocrine organs are presented.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Solitary Fibrous Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20191330.001).
  • [ISSN] 1559-0097
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 26
  •  go-up   go-down


27. Farkas A, Horányi J, Gláz E, Kulka J: [Oncocytic tumor of the adrenal gland]. Orv Hetil; 2005 Jul 3;146(27):1453-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Oncocytic tumor of the adrenal gland].
  • Oncocytic tumor of the adrenal gland.
  • The authors describe a case of a rare tumor arising in the adrenal gland.
  • The tumor 6 cm in diameter, connected to the right adrenal gland, was found incidentally in a healthy young man of 34 years of age, who suffered an accident and had a rib fracture.
  • The right adrenal gland with the tumor was removed by laparoscopic surgery.
  • Histopathological examination revealed an oncocytic adenoma of the adrenal cortex.
  • The authors describe the morphology and the differential diagnosis of this rare tumor of the adrenal gland.
  • [MeSH-major] Adenoma, Oxyphilic / diagnosis. Adrenal Gland Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Incidental Findings. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16089107.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Hungary
  • [Number-of-references] 12
  •  go-up   go-down


28. Burel-Vandenbos F, Cardot-Leccia N, Effi B, Varini JP, Saint-Paul MC, Michiels JF: [An unusual tumor of the adrenal gland]. Ann Pathol; 2005 Oct;25(5):386-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An unusual tumor of the adrenal gland].
  • [Transliterated title] Une tumeur inhabituelle de la surrénale.
  • Adenomatoid tumors are benign mesothelial tumors that usually affect the genital tract.
  • We report the case of a 65-year-old man with an adenomatoid tumor of the adrenal gland.
  • This uncommon location and its histological heterogeneity can lead to a mistaken diagnosis of malignant tumor.
  • Positive cells with mesothelial markers in immunohistochemistry improve diagnosis.
  • The proper identification of this benign tumor in the adrenal gland and the knowledge of its differential diagnosis deserve attention to avoid invasive treatment.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adrenalectomy. Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Lymphangioma / diagnosis. Male. Neoplasm Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16498291.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


29. Kim DJ, Chung JJ, Ryu YH, Hong SW, Yu JS, Kim JH: Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review. Ann Nucl Med; 2008 Nov;22(9):821-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report on the 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) findings in a case of adrenocortical oncocytoma, a rare tumor of the adrenal gland with the literature review of other imaging findings including ultrasonography, computed tomography, and magnetic resonance imaging.
  • [MeSH-major] Adenoma, Oxyphilic / radionuclide imaging. Adrenal Cortex Neoplasms / radionuclide imaging. Fluorodeoxyglucose F18. Positron-Emission Tomography / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19039562.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 19
  •  go-up   go-down


30. Koren J, Cunderlík P: [Adenomatoid tumor of the right adrenal gland: a case report]. Cesk Patol; 2005 Jul;41(3):111-4
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenomatoid tumor of the right adrenal gland: a case report].
  • [Transliterated title] Adenomatoidný tumor pravej nadoblicky: kazuistika.
  • Adenomatoid tumor of adrenal gland is a very rare primary tumor with favourable prognosis.
  • The mesothelial origin of this tumor was confirmed by multiple studies of various authors.
  • In our case report, we present an interesting case of the adenomatoid tumor of the right adrenal gland in a 55-year-old woman.
  • Our case is the second well-documented case of this tumor occurring in a female adult patient.
  • We emphasize the presence of an intraluminal thread-like bridging strands, generally considered to be a characteristic histologic feature of this tumor, which have not yet been reported in literature in adenomatoid tumor located in adrenal glands.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16161457.001).
  • [ISSN] 1210-7875
  • [Journal-full-title] Československá patologie
  • [ISO-abbreviation] Cesk Patol
  • [Language] slo
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


31. Leclair MD, de Lagausie P, Becmeur F, Varlet F, Thomas C, Valla JS, Petit T, Philippe-Chomette P, Mure PY, Sarnacki S, Michon J, Heloury Y: Laparoscopic resection of abdominal neuroblastoma. Ann Surg Oncol; 2008 Jan;15(1):117-24
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective multicenter study included 45 children with abdominal NBs (28 localized, 11 stage 4, 6 stage 4s) and laparoscopic resection of their abdominal primary tumor.
  • Primary site of the tumor was the adrenal gland in 41 cases and retroperitoneal space in 4.
  • The median age at surgery was 12 months (1-122); median tumor size was 37 mm (12-70).
  • Four procedures (9%) were converted to open surgery, and tumor rupture occurred in three cases.
  • Of the 28 children with localized disease, there was a 96% overall survival (OS) rate after a median follow-up of 28 months (4-94).
  • For the entire 45-children cohort, four children died and three presented a recurrence resulting in OS, disease-free survival, and event-free survival rates of 84% +/- 8.1, 84% +/- 8.2, and 77% +/- 9.1 respectively.
  • CONCLUSION: Laparoscopic resection of abdominal primary allows effective local control of the disease in a wide range of clinical situations of neuroblastoma, with an acceptable morbidity.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Laparoscopy. Neuroblastoma / surgery. Retroperitoneal Neoplasms / surgery
  • [MeSH-minor] Disease-Free Survival. Female. Humans. Infant. Infant, Newborn. Male. Neoplasm Staging. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17926102.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


32. Wyler SF, Bachmann A, Casella R, Tapia C, Gasser TC, Sulser T: Curative surgery for solitary adrenal metastasis of pT1 G3 transitional cell carcinoma of the bladder. Urology; 2005 Feb;65(2):388
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Curative surgery for solitary adrenal metastasis of pT1 G3 transitional cell carcinoma of the bladder.
  • A preoperative computed tomography scan in a patient undergoing radical cystectomy for pT1N0 grade 3 transitional cell carcinoma revealed a tumor in the adrenal gland.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenalectomy. Carcinoma, Transitional Cell / secondary. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15708063.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Martarelli D, Pompei P, Baldi C, Mazzoni G: Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemother Pharmacol; 2008 Apr;61(5):809-17
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adrenocortical carcinoma is a rare tumor of the adrenal gland which requires new therapeutic approaches as its early diagnosis is difficult and prognosis poor despite therapies used.
  • [MeSH-minor] Animals. Cell Line, Tumor. Cell Movement / drug effects. Cell Proliferation / drug effects. Drug Screening Assays, Antitumor. Humans. In Vitro Techniques. Male. Mice. Mice, Nude. Neoplasm Metastasis / prevention & control. Neoplasm Transplantation. Neovascularization, Pathologic / drug therapy

  • Genetic Alliance. consumer health - Adrenocortical Carcinoma.
  • Hazardous Substances Data Bank. MEBENDAZOLE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17581752.001).
  • [ISSN] 0344-5704
  • [Journal-full-title] Cancer chemotherapy and pharmacology
  • [ISO-abbreviation] Cancer Chemother. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 81G6I5V05I / Mebendazole
  •  go-up   go-down


34. Orlando R, Lumachi F, Lirussi F: Congenital anomalies of the spleen mimicking hematological disorders and solid tumors: a single-center experience of 2650 consecutive diagnostic laparoscopies. Anticancer Res; 2005 Nov-Dec;25(6C):4385-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital anomalies of the spleen mimicking hematological disorders and solid tumors: a single-center experience of 2650 consecutive diagnostic laparoscopies.
  • Though most of these anatomical variants have no clinical significance, an accessory spleen may simulate a tumor in the adrenal gland, pancreas, stomach or intestine.
  • Alternatively, a missed accessory spleen may be the site of the relapse of a hematological disorder.
  • We, therefore, assessed retrospectively: (i) the frequency of congenital anomalies of the spleen observed during 2650 consecutive laparoscopies and (ii) looked for possible misdiagnoses of the accessory spleen as hematological disorders or solid tumors located in the left upper quadrant of the abdomen.
  • Among the 44 patients in whom an accessory spleen was discovered laparoscopically, the recognition of this anomaly prevented a relapse of a hematological disease in one case and avoided a useless exploratory laparotomy in the second, where the radiologist had interpreted this malformation as a space-occupying lesion.
  • In the third case, the accessory spleen was initially misdiagnosed as a solid tumor of the pancreas, but was eventually recognized as a congenital anomaly by a second laparoscopy.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Hematologic Neoplasms / diagnosis. Spleen / abnormalities
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Laparoscopy. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16334112.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


35. Walz MK: [Adrenal tumors]. Chirurg; 2008 Nov;79(11):1087-94; quiz 1095-6
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal tumors].
  • [Transliterated title] Nebennierentumoren.
  • Adrenal tumors can be primary or secondary entities.
  • Primary tumors are able to secrete hormones which may cause significant effects clinically.
  • Typical tumor-related adrenal diseases are Conn's syndrome (hyperaldosteronism), Cushing's syndrome (hypercortisolism), and pheochromocytoma (catacholamine excess).
  • Primary adrenal tumors are rarely malignant, but adrenocortical neoplasias show a relation between tumor size and rate of malignancy.
  • Diagnostic methods for adrenal tumors include hormone tests and imaging.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Cushing Syndrome / surgery. Hyperaldosteronism / surgery. Pheochromocytoma / surgery
  • [MeSH-minor] Adrenal Glands / pathology. Adrenalectomy. Endoscopy. Humans. Minimally Invasive Surgical Procedures. Postoperative Care

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18941729.001).
  • [ISSN] 0009-4722
  • [Journal-full-title] Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


36. Willenberg HS, Zschucke D, Bornstein SR: [Adrenal gland tumors]. Internist (Berl); 2007 Sep;48(9):971-86
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal gland tumors].
  • [Transliterated title] Nebennierentumoren.
  • Adrenal masses are one of the most common tumors in humans.
  • Adrenal masses originating from steroidogenic or chromaffin cells may be silent or the source of subclinical or overt hormone excess, such as primary aldosteronism, hypercortisolism or symptomatic catecholamine excess.
  • On the other hand, adrenal hyperplasia may be the result of excess ACTH secretion in steroid biosynthesis disorders with deficient glucocorticoid secretion, in glucocorticoid resistance, in Cushing's disease, or ectopic ACTH syndrome.
  • Algorithms for endocrine testing, imaging studies and their combination are available for defining the tumor entity and for the characterization of the hormone excess syndromes.
  • Recent developments in molecular biology have provided tools for testing for hereditary tumor syndromes associated with adrenal tumorigenesis and to establish strategies for further treatment and follow-up.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / therapy
  • [MeSH-minor] Diagnosis, Differential. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17684715.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 28
  •  go-up   go-down


37. Tang JY, Pan C, Chen J, Xu M, Chen J, Xue HL, Gu LJ, Dong R, Ye H, Zhou M, Wang YP: [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases]. Zhonghua Er Ke Za Zhi; 2006 Oct;44(10):770-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
  • OBJECTIVE: The aim of the paper was to improve the prognosis of neuroblastoma (NB) stage III and IV in children through the comprehensive therapy including chemotherapy, delayed tumor resection, autologous stem cell transplantation (ASCT) and inducing differentiation and to analyze the factors affecting the prognosis.
  • Comprehensive protocol included accurate staging, delayed and/or second tumor resection for stage III and IV patients, chemotherapy of different intensity mainly composed of cell cycle nonspecific drugs and 13-cis-retinoid for inducing cell differentiation.
  • Of them, 15 were found to have the tumor in adrenal gland, 12 had the tumor extended to the retro-peritoneal space, while in 15 cases the tumor was beside the spinal column in chest and in 3 the tumor was located in other places.
  • Nine cases had stage I, 1 case had stage II, 8 cases had III, 26 cases had stage IV and 1 case had stage IVs of the tumor.
  • Depending on the age and stage of the tumor, 26 cases were aligned into high risk protocol, 10 into medium risk and 9 into low risk groups.
  • During up to 21 months median following up period (range 14 to 64 months), 24 cases (62%) kept CR (median 22 months) and 4 survived with stable disease.
  • Eleven cases died of relapse and disease progression.
  • Statistical analysis showed that the age older than 18 months, and stage III and IV of the tumor were the factors predicting poor prognosis (P = 0.04 and 0.003, respectively).
  • Patients who had the tumor originated from the retroperitoneal space, who had incomplete tumor resection, and those who did not receive ASCT had poorer prognosis, but the differences were not significant (P = 0.092, 0.55 and 0.60, respectively).
  • The origin of the tumor, completeness of tumor resection, and use of ASCT had no significant impact on the prognosis.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Hematopoietic Stem Cell Transplantation. Neuroblastoma / diagnosis. Neuroblastoma / therapy. Transplantation, Autologous
  • [MeSH-minor] Age Factors. Chemotherapy, Adjuvant. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Male. Neoplasm Recurrence, Local / prevention & control. Neoplasm Recurrence, Local / surgery. Neoplasm Recurrence, Local / therapy. Neoplasm Staging. Prognosis. Remission Induction / methods. Retrospective Studies. Severity of Illness Index. Survival Rate. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17229383.001).
  • [ISSN] 0578-1310
  • [Journal-full-title] Zhonghua er ke za zhi = Chinese journal of pediatrics
  • [ISO-abbreviation] Zhonghua Er Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


38. Varkarakis IM, Mufarrij P, Studeman KD, Jarrett TW: Adenomatoid of the adrenal gland. Urology; 2005 Jan;65(1):175
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomatoid of the adrenal gland.
  • Adenomatoid tumors are common in the genital tract but rare in the adrenal gland.
  • These tumors can be difficult to diagnose when present in extragenital sites.
  • This type of adrenal tumor lacks specific radiographic features and can be confused preoperatively with more common adrenal gland tumors.
  • We present the case of a 54-year-old man with an incidental right adrenal mass with calcified components and elevated urinary levels of homovanillic acid that was found to be an adenomatoid tumor of the adrenal gland.
  • [MeSH-major] Adenomatoid Tumor / radiography. Adrenal Gland Neoplasms / radiography. Calcinosis / radiography
  • [MeSH-minor] Biomarkers, Tumor / analysis. Calbindin 2. Homovanillic Acid / urine. Humans. Incidental Findings. Kidney Calculi / complications. Kidney Calculi / radiography. Male. Middle Aged. Neoplasm Proteins / analysis. S100 Calcium Binding Protein G / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15667895.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calbindin 2; 0 / Neoplasm Proteins; 0 / S100 Calcium Binding Protein G; X77S6GMS36 / Homovanillic Acid
  •  go-up   go-down


39. Lau SK, Weiss LM: Calcifying fibrous tumor of the adrenal gland. Hum Pathol; 2007 Apr;38(4):656-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calcifying fibrous tumor of the adrenal gland.
  • Calcifying fibrous tumor is an uncommon entity with distinctive pathologic features.
  • Most calcifying fibrous tumors involve the peripheral soft tissues or serosal surfaces, with reports of visceral examples of this lesion being extremely limited.
  • We report the clinical and pathologic features of an unusual case of calcifying fibrous tumor occurring in the adrenal gland of a 32-year-old woman.
  • The morphologic diagnosis of calcifying fibrous tumor was supported by diffuse positive immunoreactivity for factor XIIIa and absence of reactivity for muscle specific actin, smooth muscle actin, and anaplastic lymphoma kinase.
  • Although rare, awareness that calcifying fibrous tumor may occur at this particular site is important so as not to confuse this lesion with other mesenchymal neoplasms of the adrenal gland.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Calcinosis / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17078996.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.3.2.13 / Factor XIIIa
  •  go-up   go-down


40. Li ZL, Sun D, Kong CZ: [Diagnosis and treatment for the corticomedullary mixed tumor of adrenal gland]. Zhonghua Wai Ke Za Zhi; 2009 Aug 15;47(16):1239-41
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis and treatment for the corticomedullary mixed tumor of adrenal gland].
  • OBJECTIVE: To study and summarize the diagnosis and treatment for the corticomedullary mixed tumor of adrenal gland.
  • METHODS: The clinical data of 25 cases of adrenal corticomedullary mixed tumor from January 2000 to April 2008 were analyzed retrospectively, which including 9 males and 16 females.
  • Every case underwent b-ultrasound and CT normal plus extensive scan to make the diagnosis.
  • All of the cases had blood pressure fluctuation during dissection of the adrenal tumors, with the highest blood pressure reached to 230/140 mm Hg (1 mm Hg = 0.133 kPa).
  • Postoperative histopathological study revealed that the pathological changes was corticomedullary mixed tumor of adrenal gland, which was supported by immunohistochemical study.
  • CONCLUSIONS: In cases with complex phenomenon that can't explain with single cortical or medullary changes, it must beware of the mixed pathological changes in adrenal gland.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19781172.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


41. Bisceglia M, Carosi I, Scillitani A, Pasquinelli G: Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: Case presentation and review of the literature. Adv Anat Pathol; 2009 Nov;16(6):424-32
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for adenomatoid tumor .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: Case presentation and review of the literature.
  • Adenomatoid tumors (AT) are usually found in the genital tract of both sexes.
  • They are very rarely located in extragenital sites, and are exceedingly rare in the adrenal.
  • AT of the adrenal gland (AT-AG) are nonfunctioning, usually discovered incidentally and confused on imaging with other more common adrenal neoplasms.
  • Thirty-four cases have been reported so far, more often presenting grossly as solid tumors, rarely as solid with cystic areas, and 5 cases were almost entirely cystic.
  • On light microscopy the diagnosis may be very difficult if the tumor is rich in vacuolated cells, mimicking metastatic signet ring-cell adenocarcinoma.
  • The adrenal tumor was 5.5 cm in size and was fully investigated immunohistochemically and ultrastructurally.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology. Lymphangioma, Cystic / pathology
  • [MeSH-minor] Adrenal Glands / pathology. Adrenal Glands / ultrastructure. Humans. Male

  • Genetic Alliance. consumer health - Lymphangioma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19851133.001).
  • [ISSN] 1533-4031
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 39
  •  go-up   go-down


42. Benavente-Chenhalls LA, Vella A, Farley DR, Thompson GB, Grant CS, Richards ML: Malignant adrenal neoplasm masquerading as worrisome adrenal hemorrhage. Ann Surg Oncol; 2010 Oct;17(10):2710-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant adrenal neoplasm masquerading as worrisome adrenal hemorrhage.
  • BACKGROUND: Adrenal hemorrhage (AH) associated with adrenal neoplasm is rare.
  • This study assesses the clinical and pathological impact of AH in the setting of malignant adrenal neoplasm to establish management strategies.
  • MATERIALS AND METHODS: Patients admitted over a 25-year period with a diagnosis of AH and malignant adrenal neoplasm were retrospectively reviewed.
  • RESULTS: Malignant adrenal neoplasms were reported in 14 of 217 patients (6.4%) presenting with AH.
  • In 10 patients the adrenal tumor was metastatic.
  • All primary adrenal tumors were unilateral.
  • Computed tomography (n = 12) demonstrated adrenal masses ranging in size from 6.8 to 11.0 cm (mean, 9 cm).
  • CONCLUSION: Most patients with AH in the setting of malignant adrenal neoplasm had metastatic tumors to the adrenal glands.
  • These patients do not typically present in hemorrhagic shock, allowing for adequate preoperative evaluation for function and assessment for primary tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Adrenal Gland Neoplasms / diagnosis. Hemorrhage / complications. Hemorrhage / diagnosis
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Prognosis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20499282.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Zhou J, Ye D, Wu M, Zheng F, Wu F, Wang Z, Li H: Bilateral adrenal tumor: causes and clinical features in eighteen cases. Int Urol Nephrol; 2009;41(3):547-51
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral adrenal tumor: causes and clinical features in eighteen cases.
  • Bilateral adrenal neoplasms are very rare.
  • Studies have shown that most are metastatic tumors, and clinical presentation varies with tumor type.
  • We retrospectively reviewed medical records of 18 cases of bilateral adrenal tumor in our hospital between 2002 and 2007.
  • The etiology was pheochromocytoma in six, primary lymphoma in four, nonfunctioning cortical adenoma in four, metastatic tumors in two, primary aldosteronism in one, and Cushing syndrome in one.
  • Patients with lymphoma had largest average tumor size.
  • Our findings suggest that pheochromocytoma, primary lymphoma, and nonfunctioning cortical adenoma are common causes of bilateral adrenal tumor.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18850298.001).
  • [ISSN] 1573-2584
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


44. Falhammar H, Thorén M: An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence? J Endocrinol Invest; 2005 May;28(5):449-53
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence?
  • An 88-yr-old woman presented with a 3x4x5 cm adrenal incidentaloma.
  • Biopsy of the tumor showed benign adenoma tissue.
  • The genetic analysis showed two mutations in the CYP21-gene, V281L and 1172N consistent with mild non-classic congenital adrenal hyperplasia (CAH).
  • Previous reports have shown increased prevalence of CAH in patients with adrenal tumors although, to our knowledge, no one has reported the combination in a patient as old as in ours.
  • Thus, clinical signs and symptoms of CAH should be looked for in patients with adrenal incidentalomas, even in the very old ones, and if suspicion further diagnostic work-up should be carried out to provide adequate treatment and follow-up.
  • [MeSH-major] Adenoma / pathology. Adrenal Gland Neoplasms / pathology. Adrenal Hyperplasia, Congenital / pathology


45. Ueberberg B, Tourne H, Redmann A, Walz MK, Schmid KW, Mann K, Petersenn S: Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res; 2005 Dec;37(12):722-8
Hazardous Substances Data Bank. HYDROCORTISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
  • Somatostatin (SRIF) is a widely distributed peptide with growth-inhibiting effects in various tumors.
  • We investigated expression of the five ssts in various adrenal tumors and in normal adrenal gland.
  • Adrenal tissue surrounding the tumor was available for analysis in twenty-seven cases.
  • Expression of all five receptor subtypes was observed in RNA obtained from normal adrenal gland.
  • Furthermore, each receptor subtype was expressed in more than 50 % of all tumors analyzed.
  • No sst5 expression was found in PHEOs, while sst1 was present in nearly all of these tumors.
  • Differential expression of ssts in various adrenal tumors may point to new aspects in the pathogenesis of these adenomas.
  • New subtype specific analogues of SRIF may be used in the future depending on the type of adrenal tumor and receptor subtype expressed.
  • [MeSH-major] Adrenal Gland Neoplasms / metabolism. Adrenal Glands / metabolism. Receptors, Somatostatin / metabolism

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Horm Metab Res. 2006 Sep;38(9):617. Redman, A [corrected to Redmann, A]
  • (PMID = 16372224.001).
  • [ISSN] 0018-5043
  • [Journal-full-title] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme
  • [ISO-abbreviation] Horm. Metab. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Receptors, Somatostatin; 63231-63-0 / RNA; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


46. Shiozawa M, Sata N, Endo K, Koizumi M, Yasuda Y, Nagai H, Takakusaki H: Preoperative virtual simulation of adrenal tumors. Abdom Imaging; 2009 Jan-Feb;34(1):113-20
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative virtual simulation of adrenal tumors.
  • BACKGROUND: Retroperitoneal endoscopic adrenalectomy (EA) is recognized as a principal procedure for benign adrenal tumors.
  • However, a limited visual field and a narrow working space make this approach difficult, particularly in cases of obese patients or small tumors.
  • Using multidetector row CT (MD-CT), this study investigated the use of preoperative virtual simulation (PVS) to identify tumor and central vein locations for EA, and verified these findings during EA surgery.
  • PATIENTS AND METHODS: The study enrolled 11 cases comprising 10 adrenal adenomas and one ACTH-independent macronodular adrenal hyperplasia admitted to Jichi Medical University Hospital, Tochigi, Japan, between November 2003 and October 2006.
  • 3D PVS images of ribs, vertebrae, kidneys, and adrenal tumors were generated and compared with real images obtained during EA.
  • RESULTS: The PVS images clearly showed the relative locations of the adrenal tumor, kidney, and adjacent anatomical structures.
  • [MeSH-major] Adrenal Gland Neoplasms / radiography. Adrenocortical Adenoma / radiography. Imaging, Three-Dimensional / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18253779.001).
  • [ISSN] 1432-0509
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Horstmann M, Merseburger AS, Stenzl A, Kuczyk M: [Systemic therapy of malignant adrenal tumors]. Urologe A; 2006 May;45(5):605-8
MedlinePlus Health Information. consumer health - Palliative Care.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Systemic therapy of malignant adrenal tumors].
  • [Transliterated title] Systemische Therapie maligner Nebennierentumoren.
  • Systemic treatment of advanced-stage adrenal malignancies is most often only palliative.
  • Mitotane alone or in combination with other chemotherapeutic agents such as cisplatin, etoposide, and vincristine are established therapeutic concepts for the treatment of metastatic adrenal cancer.
  • New therapeutic options are tumor vaccination and treatment with antiangiogenic drugs.
  • [MeSH-major] Adrenal Gland Neoplasms / drug therapy. Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant / methods. Neoplasm Recurrence, Local / prevention & control. Palliative Care / methods. Terminal Care / methods

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16622644.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Number-of-references] 31
  •  go-up   go-down


48. Izaki H, Fukumori T, Takahashi M, Taue R, Kishimoto T, Tanimoto S, Nishitani MA, Kanayama HO: Indications for laparoscopic adrenalectomy for non-functional adrenal tumor with hypertension: usefulness of adrenocortical scintigraphy. Int J Urol; 2006 Jun;13(6):677-81
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Indications for laparoscopic adrenalectomy for non-functional adrenal tumor with hypertension: usefulness of adrenocortical scintigraphy.
  • AIM: Laparoscopic adrenalectomy is currently indicated for biochemically and clinically functional adrenal tumors and potentially malignant tumors of the adrenal glands.
  • Non-functional adenomas greater than 5 cm in diameter of the adrenal gland are generally considered to represent potentially malignant tumors.
  • The present study shows indications of laparoscopic adrenalectomy for non-functional adrenal tumors with hypertension in a retrospective fashion.
  • Forty-five patients underwent laparoscopic adrenalectomy for non-functional adrenal tumors, and [(131)I]6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol (NP-59) scintigraphy was performed for patients with preoperative hypertension.
  • Mean maximum tumor diameter was 42 mm (range, 20-105 mm).
  • All adrenal tumors were removed successfully by laparoscopic surgery.
  • Importantly, all patients who improved hypertension after adrenalectomy displayed strong accumulation in adrenal tumors with visualization of the contralateral gland on NP-59 scintigraphy.
  • CONCLUSIONS: The indication of laparoscopic adrenalectomy for non-functional adrenal tumors is generally considered for lesions more than 5 cm diameter.
  • However, the present study suggests that laparoscopic surgery should be considered even in patients with tumors less than 5 cm in diameter, if both hypertension and accumulation in tumors on NP-59 scintigraphy are present.
  • [MeSH-major] Adenoma / radiography. Adenoma / therapy. Adrenal Gland Neoplasms / radiography. Adrenal Gland Neoplasms / therapy. Adrenalectomy. Laparoscopy

  • Genetic Alliance. consumer health - Adrenal Hypertension.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16834641.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


49. Ridho FE, Adam FM, Adam JM: Adrenal incidentaloma. Acta Med Indones; 2009 Apr;41(2):87-93
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal incidentaloma.
  • Adrenal Incidentaloma is an adrenal tumor, which is unidentified before the imaging procedures conducted for an abnormality which is initially unforeseen as an adrenal disease.
  • Symptoms and/or clinical signs of adrenal tumor do not have to be present prior to a diagnosis.
  • Adrenal Incidentaloma can be divided into non-hypersecreting adrenal adenoma, hypersecreting tumor, primary adrenal carcinoma, other adrenal mass, and metastases.
  • The majority of adrenal tumor is non-hypersecreting adrenal adenoma, but it is always considered as hypersecreting tumor until proven otherwise.
  • Some conditions that can be found due to hormonal activity of adrenal incidentaloma is subclinical Cushing's syndrome, pheochromocytoma, aldosteronoma (Conn's disease), and several tumors which secrete androgen and sex hormone.
  • Diagnostic approach of adrenal incidentaloma is focused on two main problems, which are, whether the lesion is hormonally active even though lacking characteristic clinical signs, and whether the lesion is benign or malignant; thus it needs hormonal and radiologic evaluation, even a fine needle biopsy.
  • The management for adrenal incidentaloma includes surgical removal for hormonally active adrenal tumors, or inactive tumors with size less than 4 cm.
  • Monitoring of tumor's hormone level and size are necessary for non-hypersecreting tumor without surgical removal.
  • [MeSH-major] Adrenal Gland Neoplasms. Aldosterone / blood. Catecholamines / urine. Incidental Findings. Renin / blood
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Humans. Indonesia / epidemiology. Morbidity / trends

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19390128.001).
  • [ISSN] 0125-9326
  • [Journal-full-title] Acta medica Indonesiana
  • [ISO-abbreviation] Acta Med Indones
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Indonesia
  • [Chemical-registry-number] 0 / Catecholamines; 4964P6T9RB / Aldosterone; EC 3.4.23.15 / Renin
  • [Number-of-references] 38
  •  go-up   go-down


50. Igaz P, Wiener Z, Szabó P, Falus A, Gaillard RC, Horányi J, Rácz K, Tulassay Z: Functional genomics approaches for the study of sporadic adrenal tumor pathogenesis: clinical implications. J Steroid Biochem Mol Biol; 2006 Oct;101(2-3):87-96
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Functional genomics approaches for the study of sporadic adrenal tumor pathogenesis: clinical implications.
  • Although sporadic adrenal tumors are frequently encountered in the general population their pathogenesis is not well elucidated.
  • Some studies have already been published describing gene expression profiles of benign and malignant adrenocortical tumors and phaeochromocytomas.
  • Several genes coding for growth factors and their receptors, enzymes involved in steroid hormone biosynthesis, genes related to the regulation of cell cycle, cell proliferation, adhesion and intracellular metabolism have been found to be up- or downregulated in various tumors.
  • Some alterations in gene expression appear so specific for certain tumor types that their application in diagnosis, determination of prognosis and the choice of therapy can be envisaged.
  • In this short review, the authors will present a synopsis of these recent findings that seem to open new perspectives in adrenal tumor pathogenesis, with emphasis on changes in steroidogenic enzyme expression profiles and highlighting possible clinical implications.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Biomarkers, Tumor / analysis. Chromosome Aberrations. Genomics / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16891114.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 89
  •  go-up   go-down


51. Tomasich FD, Luz Mde A, Kato M, Targa GZ, Dias LA, Zucoloto FJ, Ogata DC: [Primary adrenal leiomyosarcoma]. Arq Bras Endocrinol Metabol; 2008 Dec;52(9):1510-4
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adrenal leiomyosarcoma].
  • [Transliterated title] Leiomiossarcoma primário de adrenal.
  • Leiomyosarcoma of adrenal gland is an extremely rare tumor originating from the central adrenal vein or its tributaries.
  • Patients with human immunodeficiency virus (HIV) and Epstein-Barr infection have a higher incidence of these tumors, but even in those, the overall incidence is very low.
  • In this paper we report a case of a 48 year-old woman whose diagnosis was made by image exams that had suggested a mass in adrenal area.
  • The histopathologic and immunohistochemistry exams were compatible with primary leiomyosarcoma of adrenal gland.
  • Fifty-three months after adrenalectomy the patient died with recurrent disease.
  • Despite of the rarity of this tumor, leiomyosarcoma of adrenal gland has an aggressive behavior, such as the others soft tissue sarcomas.
  • The adrenalectomy is the primary treatment, while chemotherapy or radiotherapy is not prescribed except in metastatic or bulky and inoperable disease.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Leiomyosarcoma / pathology

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19197462.001).
  • [ISSN] 1677-9487
  • [Journal-full-title] Arquivos brasileiros de endocrinologia e metabologia
  • [ISO-abbreviation] Arq Bras Endocrinol Metabol
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 13
  •  go-up   go-down


52. Komatsu S, Watanabe R, Naito M, Mizusawa T, Obara K, Nishiyama T, Takahashi K: Primitive neuroectodermal tumor of the adrenal gland. Int J Urol; 2006 May;13(5):606-7
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primitive neuroectodermal tumor of the adrenal gland.
  • We report a rare case of primitive neuroectodermal tumor arising from adrenal gland in adulthood, diagnosed preoperatively as having non-functional adrenocortical adenoma.
  • Immunohistological examination revealed the definite diagnosis as primitive neuroectodermal tumor of the adrenal gland.
  • Although primitive neuroectodermal tumor is a highly malignant neoplasm, there is no evidence of local recurrence and distant metastasis 16 months after surgery.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Neuroectodermal Tumors, Primitive / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16771733.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules
  •  go-up   go-down


53. Hattori Y, Kanamoto N, Kawano K, Iwakura H, Sone M, Miura M, Yasoda A, Tamura N, Arai H, Akamizu T, Nakao K, Maitani Y: Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma. Int J Oncol; 2010 Sep;37(3):695-705
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.
  • Adrenal neuroblastoma and pheochromocytoma have the same embryonic origin from neural crest cells and mainly arise from the adrenal medulla.
  • Recently, transgenic mice exhibiting tumors in the bilateral adrenal medulla by the expression of SV40 T-antigen were developed.
  • In this study, we investigated mRNA expression in adrenal tumors of transgenic mice and compared them with human pheochromocytoma by DNA microarray analysis.
  • To compare mouse adrenal tumors and human pheochromacytoma, we found that the expressions of noradrenergic neuron-related genes, including dopa decarboxylase, phenylethanolamine-N-methyltransferase and chromogranin B, were up-regulated in humans but not in mice; however, the expression of neuroblastoma-related genes, including Mycn, paired-like homeobox 2b, gamma-aminobutyric acid A receptor beta3 subunit, islet 1 and kinesin family member 1A, was up-regulated in both species.
  • From the gene expression profiles, the characterization of mouse adrenal tumor, may be similar to that of human adrenal neuroblastoma rather than pheochromacytomas.
  • This mouse model would be a useful tool for the development of anti-cancer drugs and for understanding the etiology of adrenal neuroblastoma.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Pheochromocytoma / genetics
  • [MeSH-minor] Animals. Antigens, Polyomavirus Transforming / biosynthesis. Disease Models, Animal. Gene Expression Regulation, Neoplastic. Humans. Mice. Mice, Inbred C57BL. Mice, Transgenic. Oligonucleotide Array Sequence Analysis. RNA, Messenger / biosynthesis. RNA, Messenger / genetics. Up-Regulation


54. Cyriac J, Weizman D, Urbach DR: Laparoscopic adrenalectomy for the management of benign and malignant adrenal tumors. Expert Rev Med Devices; 2006 Nov;3(6):777-86
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy for the management of benign and malignant adrenal tumors.
  • Laparoscopic adrenalectomy has become the preferred approach for removal of the adrenal gland.
  • Adrenalectomy is usually required for the removal of adrenal tumors causing excess hormone production or because a malignant adrenal tumor cannot be excluded.
  • Current controversies include the appropriateness of laparoscopic adrenalectomy for large or malignant tumors, the role of partial adrenalectomy and the management of some conditions with uncertain natural history (such as subclinical hypercortisolism).
  • With the increased use of sensitive cross-sectional imaging, the detection of clinically inapparent adrenal masses is likely to continue to increase.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17280543.001).
  • [ISSN] 1743-4440
  • [Journal-full-title] Expert review of medical devices
  • [ISO-abbreviation] Expert Rev Med Devices
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 63
  •  go-up   go-down


55. Gross MD, Djekidel M, Hay RV, Rubello D: Scintigraphic localization of adrenal tumors. Minerva Endocrinol; 2009 Jun;34(2):171-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scintigraphic localization of adrenal tumors.
  • Scintigraphy has historically added much to the evaluation of adrenal dysfunction and tumor localization.
  • The parallel emergence of radiopharmaceuticals for adrenomedullary imaging also provided important functional insight in evaluating these neoplasms, but despite the clinical value of such nuclear probes they too, were relegated to a less prominent role in tumor characterization because of advances in anatomic imaging.
  • However, with the recent introduction of dual-modality imaging platforms that directly combine CT with scintigraphy, either as single photon emission tomography (SPECT)/CT or positron emission tomography (PET)/CT, nuclear medicine studies once again play an integral role in adrenal tumor evaluation.
  • [MeSH-major] Adrenal Gland Neoplasms / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, Emission-Computed, Single-Photon
  • [MeSH-minor] Adrenal Cortex Neoplasms / radionuclide imaging. Adrenal Gland Diseases / radionuclide imaging. Adrenocortical Carcinoma / radionuclide imaging. Cushing Syndrome / radionuclide imaging. Diagnosis, Differential. Humans. Incidental Findings. Pheochromocytoma / radionuclide imaging. Reproducibility of Results. Sensitivity and Specificity. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19333218.001).
  • [ISSN] 0391-1977
  • [Journal-full-title] Minerva endocrinologica
  • [ISO-abbreviation] Minerva Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Radiopharmaceuticals
  • [Number-of-references] 93
  •  go-up   go-down


56. Gaisa NT, Klöppel G, Brehmer B, Neulen J, Stephan P, Knüchel R, Donner A: [Virilizing adrenal ganglioneuroma : A rare differential diagnosis in testosterone secreting adrenal tumours]. Pathologe; 2009 Sep;30(5):407-10
Hazardous Substances Data Bank. TESTOSTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Virilizing adrenal ganglioneuroma : A rare differential diagnosis in testosterone secreting adrenal tumours].
  • [Transliterated title] Virilisierendes Ganglioneurom der Nebenniere : Eine seltene Differenzialdiagnose testosteronproduzierender Nebennierentumoren.
  • Testosterone secreting tumours of the adrenal glands are usually adrenal carcinomas or adenomas.
  • Here we report the rare case of an adrenal ganglioneuroma with ectopic Leydig cells, a so-called virilizing adrenal ganglioneuroma.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Adrenal Gland Neoplasms / secretion. Ganglioneuroma / pathology. Ganglioneuroma / secretion. Testosterone / secretion. Virilism / pathology
  • [MeSH-minor] Adrenal Cortex / pathology. Adrenal Gland Diseases / pathology. Adrenal Gland Diseases / surgery. Adrenalectomy. Aged. Biomarkers, Tumor / analysis. Calbindin 2. Choristoma / pathology. Choristoma / surgery. Diagnosis, Differential. Female. Humans. Inhibins / analysis. Laparoscopy. Leydig Cells. Male. S100 Calcium Binding Protein G / analysis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19396442.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G; 3XMK78S47O / Testosterone; 57285-09-3 / Inhibins
  •  go-up   go-down


57. Qin ZK, Zhou FJ, Dai YP, Chen W, Hou JH, Han H, Liu ZW, Yu SL, Zhang DZ, Yang JA: [Expression and clinical significance of survivin and PTEN in adrenal tumors]. Ai Zheng; 2007 Oct;26(10):1143-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and clinical significance of survivin and PTEN in adrenal tumors].
  • BACKGROUND & OBJECTIVE: Since the histomorphology of adrenal tumor is very special, it is difficult to assess the malignancy of the tumors.
  • This study was to explore the expression and clinical significance of Survivin and PTEN proteins in adrenal tumors.
  • METHODS: The expression of Survivin and PTEN in 116 specimens of adrenal tumors, including 39 cases of cortex adenoma, 22 cases of cortex adenocarcinoma, 35 cases of pheochromocytoma, and 20 cases of malignant pheochromocytoma, were detected by LSAB immunohistochemistry.
  • The expression intensity of Survivin was correlated to that of PTEN in adrenal tumors (r=-0.486, P<0.05).
  • The expression intensity of Survivin and PTEN in adrenal tumors were not related to patient's age, sex, tumor position, and so on (P>0.05).
  • The expression intensity of Survivin was significantly lower in adrenal cortex adenoma than in adrenal cortex adenocarcinoma (P<0.05), and was significantly lower in pheochromocytoma than in malignant pheochromocytoma (P<0.05).
  • The expression intensity of PTEN was related to the differentiation of adrenal tumor.
  • The expression intensity of PTEN was significantly higher in adrenal cortex adenoma than in adrenal cortex adenocarcinoma (P<0.05), and was significantly higher in pheochromocytoma than in malignant pheochromocytoma (P<0.05).
  • The expression of Survivin protein and PTEN protein was correlated to the prognosis of adrenal cortex adenocarcinoma and malignant pheochromocytoma: the higher the expression intensity of Survivin protein and the lower the expression intensity of PTEN protein, the worse the patient's prognosis (P<0.05).
  • CONCLUSION: The expression of Survivin and PTEN proteins are closely related to the prognosis of adrenal tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / metabolism. Adrenocortical Adenoma / metabolism. Adrenocortical Carcinoma / metabolism. Microtubule-Associated Proteins / metabolism. PTEN Phosphohydrolase / metabolism. Pheochromocytoma / metabolism

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17927889.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


58. Kita M, Tamaki G, Okuyama M, Saga Y, Kakizaki H: Adrenalectomy for metastatic adrenal tumors. Hinyokika Kiyo; 2007 Nov;53(11):761-6
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenalectomy for metastatic adrenal tumors.
  • The indications for adrenalectomy in cases of metastatic adrenal tumor remain controversial.
  • To clarify indications and outcomes of adrenalectomy for adrenal metastasis, we performed a retrospective review of all 8 patients who underwent adrenalectomy for adrenal metastasis between 1990 and 2006 in Asahikawa Medical College Hospital.
  • The Primary tumor was renal cell carcinoma in 2 cases, and eccrine poro carcinoma, rectal cancer, lung cancer, melanoma, bladder cancer and cancer of unknown origin in 1 case each.
  • Of the 4 patients with solitary adrenal metastasis, 3 were considered tumor-free after adrenalectomy, while the remaining patient was not due to unresectable primary tumor.
  • Of the 2 patients with other resectable metastasis who were tumor-free after removal of all metastases, one was alive 31 months postoperatively and the other died 23 months after operation.
  • At least in cases of solitary adrenal metastasis, adrenalectomy can be effective if other valid methods are unavailable.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Adrenalectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18051798.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


59. Füredi G, Szilágyi A, Bencsik Z, Altorjay A: [Adenomatoid tumor of the adrenal gland. Case report and review of the literature]. Orv Hetil; 2007 Aug 19;148(33):1563-5
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenomatoid tumor of the adrenal gland. Case report and review of the literature].
  • [Transliterated title] A mellékvese adenomatoid tumora, avagy irodalmi barangolás egy igen ritka mesothelialis daganat nyomán.
  • Adenomatoid tumors of the adrenal gland are rather rare, asymptomatic neoplasias with benign behavior and usually are diagnosed incidentally.
  • The authors report a case of an adenomatoid tumor of the right adrenal gland in a 32-year-old man who sought evaluation because of fever and renal pain.
  • During investigation a tumor, localized in right adrenal gland, was identified by ultrasonography and CT.
  • The patient underwent adrenalectomy with histopathological and immunohistochemical diagnosis of adenomatoid tumor of the adrenal gland.
  • Based on literature data the epidemiology, symptoms, differential diagnosis, treatments, histopathology and prognosis of adenomatoid tumors of the adrenal gland are discussed.
  • [MeSH-major] Adenomatoid Tumor. Adrenal Gland Neoplasms
  • [MeSH-minor] Adrenalectomy. Adult. Biomarkers, Tumor / analysis. Diagnosis, Differential. Fever / etiology. Humans. Immunohistochemistry. Male. Pain / etiology. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17686675.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 11
  •  go-up   go-down


60. Zografos GN, Farfaras A, Vasiliadis G, Pappa T, Aggeli C, Vassilatou E, Kaltsas G, Piaditis G: Laparoscopic resection of large adrenal tumors. JSLS; 2010 Jul-Sep;14(3):364-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic resection of large adrenal tumors.
  • BACKGROUND: Laparoscopic adrenalectomy has rapidly replaced open adrenalectomy as the procedure of choice for benign adrenal tumors.
  • It still remains to be clarified whether the laparoscopic resection of large (≥ 8 cm) or potentially malignant tumors is appropriate or not due to technical difficulties and concern about local recurrence.
  • Fifteen patients with tumors ≥ 8 cm underwent laparoscopic adrenalectomy.
  • Tumor size ranged from 3.2 cm to 27 cm.
  • The largest laparoscopically excised tumors were a ganglioneuroma with a mean diameter of 13 cm and a myelolipoma of 14 cm.
  • There were no conversions in the group of patients with tumors > 8 cm.
  • In the large adrenal tumor group, operative time for laparoscopic resection ranged from 150 minutes to 240 minutes.
  • The mean postoperative stay was 2 days for the group with large tumors resected by laparoscopy.
  • CONCLUSION: Laparoscopic resection of large (≥ 8 cm) adrenal tumors is feasible and safe.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1992 Oct 1;327(14):1033 [1387700.001]
  • [Cites] Ann Surg. 1984 Jan;199(1):116-22 [6691725.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):238-46; discussion 246-7 [9339930.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 1998 Jun;8(3):119-24 [9681423.001]
  • [Cites] Ann Chir. 1998;52(4):364-8 [9752471.001]
  • [Cites] World J Surg. 1999 Apr;23(4):389-96 [10030863.001]
  • [Cites] Br J Surg. 1999 Mar;86(3):385-7 [10201784.001]
  • [Cites] Semin Surg Oncol. 1999 Jun;16(4):293-306 [10332775.001]
  • [Cites] Br J Surg. 1999 May;86(5):656-60 [10361189.001]
  • [Cites] Surg Endosc. 1999 Jul;13(7):715-7 [10384082.001]
  • [Cites] Am J Surg. 1999 Jul;178(1):50-3; discussion 54 [10456703.001]
  • [Cites] Langenbecks Arch Surg. 1999 Aug;384(4):366-9 [10473857.001]
  • [Cites] JSLS. 2004 Oct-Dec;8(4):314-9 [15554272.001]
  • [Cites] Surgery. 2004 Dec;136(6):1129-37 [15657566.001]
  • [Cites] Int J Urol. 2005 Feb;12(2):134-9 [15733106.001]
  • [Cites] J Endourol. 2005 Jun;19(5):537-40 [15989440.001]
  • [Cites] Hormones (Athens). 2006 Jan-Mar;5(1):52-6 [16728385.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Aug;91(8):3080-3 [16720665.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):483-99 [16980207.001]
  • [Cites] JSLS. 2007 Jan-Mar;11(1):30-3 [17651553.001]
  • [Cites] JSLS. 2007 Apr-Jun;11(2):261-5 [17761094.001]
  • [Cites] BJU Int. 2007 Nov;100(5):1126-9 [17784884.001]
  • [Cites] JSLS. 2007 Oct-Dec;11(4):487-92 [18237516.001]
  • [Cites] Surg Endosc. 2008 Mar;22(3):617-21 [18071798.001]
  • [Cites] JSLS. 2008 Oct-Dec;12(4):380-4 [19275853.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2009 Apr;19(2):181-9 [19216698.001]
  • [Cites] J Endourol. 2009 Jun;23(6):971-5 [19456243.001]
  • [Cites] JSLS. 2009 Apr-Jun;13(2):196-202 [19660215.001]
  • [Cites] JSLS. 2009 Apr-Jun;13(2):260-2 [19660229.001]
  • [Cites] Surgery. 2000 Dec;128(6):973-82;discussion 982-3 [11114632.001]
  • [Cites] Int Surg. 1994 Jul-Sep;79(3):253-8 [7883508.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2009 Aug;19(4):336-7 [19692886.001]
  • [Cites] Surg Endosc. 2001 Jan;15(1):90-3 [11178771.001]
  • [Cites] J Urol. 2001 Aug;166(2):429-36 [11458042.001]
  • [Cites] Cancer. 2001 Sep 1;92(5):1113-21 [11571723.001]
  • [Cites] Int J Clin Pract. 2002 May;56(4):319-20 [12074221.001]
  • [Cites] Arch Surg. 2002 Aug;137(8):948-51; discussion 952-3 [12146996.001]
  • [Cites] World J Surg. 2002 Aug;26(8):1043-7 [12045859.001]
  • [Cites] J Urol. 2002 Dec;168(6):2528-9 [12441957.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Apr;13(2):106-10 [12709616.001]
  • [Cites] Ann Surg Oncol. 2003 Dec;10(10):1191-6 [14654476.001]
  • [Cites] Surg Clin North Am. 2004 Jun;84(3):755-74 [15145233.001]
  • [ErratumIn] JSLS. 2012 Jan-Mar;16(1):189. Vasilatou, Evagelina [corrected to Vassilatou, Evangeline]
  • (PMID = 21333189.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3041032
  •  go-up   go-down


61. Barzon L, Trevisan M, Masi G, Pacenti M, Sinigaglia A, Macchi V, Porzionato A, De Caro R, Favia G, Iacobone M, Palù G: Detection of polyomaviruses and herpesviruses in human adrenal tumors. Oncogene; 2008 Jan 31;27(6):857-64
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of polyomaviruses and herpesviruses in human adrenal tumors.
  • The presence of polyomaviruses and herpesviruses in adrenal tumors and their role in adrenal tumorigenesis has never been investigated, even though the adrenal gland seems to be a preferential site of infection by these viruses and adrenal steroid hormones have been shown to activate their replication.
  • We examined in a large series of normal adrenal gland tissues (n=20) and adrenal tumors (n=107) the presence of herpesviruses and polyomaviruses sequences and gene expression, which were detected in a high proportion of both normal and neoplastic adrenal samples (overall, viruses were found in 15% normal adrenals, 27.8% benign adrenal tumors and 35.3% malignant tumors).
  • The polyomaviruses SV40 and BK virus were more frequently found in malignant adrenal tumors, whereas herpesviruses, especially Epstein-Barr virus and human cytomegalovirus, were more frequently detected in functioning benign adrenocortical tumors, often as coinfection.
  • Moreover, tumors from patients with severe hypercortisolism frequently showed herpesvirus coinfections at high viral genome copy number.
  • Our study suggests that the adrenal gland could be a reservoir of infection for these viruses and that hormone overproduction by the adrenal gland could represent a trigger for virus reactivation.
  • On the other hand, these viruses could also contribute to adrenal cell proliferation and tumorigenesis.
  • [MeSH-major] Adrenal Gland Neoplasms / virology. Herpesviridae / isolation & purification. Herpesviridae Infections / virology. Polyomavirus / isolation & purification. Polyomavirus Infections / virology. Tumor Virus Infections / virology
  • [MeSH-minor] Antigens, Viral, Tumor / analysis. Base Sequence. DNA, Viral / chemistry. DNA, Viral / genetics. DNA, Viral / isolation & purification. Humans. Immunohistochemistry. Molecular Sequence Data. Sequence Analysis, DNA

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17684484.001).
  • [ISSN] 1476-5594
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Viral, Tumor; 0 / DNA, Viral
  •  go-up   go-down


62. Rescorla FJ: Malignant adrenal tumors. Semin Pediatr Surg; 2006 Feb;15(1):48-56
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant adrenal tumors.
  • Adrenal tumors, apart from neuroblastoma, are relatively rare in infancy and childhood.
  • Most adrenal lesions are benign, and both benign and malignant tumors may be hormonally active thus, making accurate preoperative diagnosis difficult.
  • The two main malignant tumors are adrenocortical carcinoma and pheochromocytoma.
  • In both tumors, it may be difficult to determine benign from malignant and the biologic behavior and degree of invasion may portend a more malignant course.
  • Surgical excision is the primary therapy for both tumors, including excision of metastatic and recurrent tumor.
  • An open procedure should be considered for invasive adrenocortical carcinoma and in pheochromocytomas in which preoperative imaging demonstrates metastatic nodal disease.
  • Chemotherapy, although without proven efficacy, is utilized in some children with metastatic or unresectable disease.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / therapy. Adrenocortical Carcinoma / diagnosis. Adrenocortical Carcinoma / therapy. Pheochromocytoma / diagnosis. Pheochromocytoma / therapy

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16458846.001).
  • [ISSN] 1055-8586
  • [Journal-full-title] Seminars in pediatric surgery
  • [ISO-abbreviation] Semin. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 98
  •  go-up   go-down


63. Vincent C, Brewster JB, Kedar V, Sundaram CP: Unilateral idiopathic adrenal hematomas with a preoperative diagnosis of indeterminate adrenal tumors. J Endourol; 2008 May;22(5):995-7
Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unilateral idiopathic adrenal hematomas with a preoperative diagnosis of indeterminate adrenal tumors.
  • PURPOSE: To identify the clinical and radiologic features of unilateral adrenal hematomas in adults.
  • PATIENTS AND METHODS: From our database of 75 patients who underwent adrenalectomies at our institution, we identified 3 patients who underwent adrenalectomy for adrenal tumors.
  • The pathology report confirmed adrenal hematomas with no evidence of neoplasm.
  • CONCLUSION: Unilateral adrenal hematomas sometimes are indistinguishable radiologically from neoplasms.
  • Surgery is then necessary to distinguish a hematoma from a hemorrhagic adrenal tumor.

  • MedlinePlus Health Information. consumer health - Adrenal Gland Disorders.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CLOPIDOGREL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18393646.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Platelet Aggregation Inhibitors; A74586SNO7 / clopidogrel; OM90ZUW7M1 / Ticlopidine; R16CO5Y76E / Aspirin
  •  go-up   go-down


64. Nunes ML, Rault A, Teynie J, Valli N, Guyot M, Gaye D, Belleannee G, Tabarin A: 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J Surg; 2010 Jul;34(7):1506-10
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
  • BACKGROUND: 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) has been proposed for the evaluation of adrenal tumors.
  • However, only scarce data are available to evaluate its usefulness for the identification of primary adrenal carcinomas in patients with no previous history of cancer and equivocal tumors on computed tomography (CT) scan.
  • Twenty-three consecutive patients without previous history of cancer investigated for adrenal tumors without features of benign adrenocortical adenoma on CT scan but no obvious ACC underwent 18F-FDG PET.
  • The ratio of maxSUV adrenal tumor on maxSUV liver (adrenal/liver maxSUV ratio) during 18F-FDG PET was compared to Weiss pathological criteria.
  • RESULTS: Seventeen patients had an adrenal adenoma, 2 had small size adrenal carcinomas (<5 cm), 1 had an angiosarcoma, and 3 had noncortical benign lesions.
  • An adrenal/liver maxSUV ratio above 1.6 provided 100% sensitivity, 90% specificity, and 100% negative predictive value for the diagnosis of malignant tumor.
  • CONCLUSIONS: Because of its excellent negative predictive value, 18F-FDG-PET may be of help in avoiding unnecessary surgery in patients with non-secreting equivocal tumors at CT scanning and low 18F-FGD uptake.
  • [MeSH-major] Adrenal Cortex Neoplasms / radionuclide imaging. Adrenal Gland Neoplasms / radiography. Fluorodeoxyglucose F18. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20396886.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


65. Słonina J, Nienartowicz E, Agrawal AK, Malczewska J, Moroń K: [The usefulness of contrast-enhanced sonography in the differential diagnostic of adrenal tumors]. Endokrynol Pol; 2006 May-Jun;57(3):230-6
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The usefulness of contrast-enhanced sonography in the differential diagnostic of adrenal tumors].
  • [Transliterated title] Przydatność ultrasonograficznego środka kontrastujacego Levovist w diagnostyce róznicowej guzów nadnerczy.
  • INTRODUCTION: The occurrence of gland tumors causes significant clinical problem.
  • Non hormone-secreting tumors provide the most complicated diagnostic difficulties.
  • The authors believe that this new method make possible the differential adrenal tumor diagnostic process more precise and increase the specificity of ultrasonography in the recognition of benign and malignant tumors.
  • The aim of this study was to define the usefulness of contrasting agent Levovist in differential diagnostics of adrenal tumors and its influence on sensitivity and specificity of ultrasound examination and to establish patients qualification criteria for surgical procedures.
  • MATERIAL AND METHODS: Ultrasound examinations were made with the use of digital devise by GE Voluson 740, probe 4-6 mHz with Doppler options and volumetric probe 3D according to the following protocol: 26 patients with recognized adrenal tumor were qualified for the examination.
  • Patients in the first stage of tumor vascularization had Doppler examination with color (CD) and power Doppler (PD).
  • RESULTS: 26 cases of adrenal gland tumours were subjected to analysis.
  • 3D ultrasound could be useful in cases of big adrenal tumors--over 3 cm diameter after application of ultrasound contrast agents.
  • 2. The use of Levovist in Doppler examination improves the visualization of tumor vascularization.
  • However, it is impossible to differentiate benign from malignant tumors unequivocally.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnostic imaging. Contrast Media. Imaging, Three-Dimensional. Polysaccharides
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neovascularization, Pathologic / diagnostic imaging. Sensitivity and Specificity. Thyroid Diseases / diagnostic imaging. Ultrasonography, Doppler, Color

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16832787.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Polysaccharides; 127279-08-7 / SHU 508
  •  go-up   go-down


66. Stehr C, Velasco S, Velasco A, López M JM: [Is adrenal tumor size related to evolution time or does it represent a biological difference?]. Rev Med Chil; 2007 Dec;135(12):1526-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Is adrenal tumor size related to evolution time or does it represent a biological difference?].
  • [Transliterated title] El tamaño de los tumores suprarrenales ¿está en relación al tiempo de evolución o expresa una diferencia biológica?
  • BACKGROUND: Adrenal tumor (AT) malignancy has been related to tumor size.
  • Since laparoscopic surgery is being used, smaller adrenal tumors are being excised.
  • AIM: To evaluate eventual clinical and histological differences between adrenal tumors smaller than 4 cm. and those larger than 6 cm.
  • PATIENTS AND METHODS: Retrospective review of pathological reports and clinical records of patients operated for adrenal tumors, dividing them in two groups.
  • Group 1 had 29 patients aged 52 +/- 13 years with AT < 4 cm operated during the period 2000-2005, and Group 2 was formed by 52 patients aged 46 +/-18 years with AT >6 cm operated between 1984-2005- Tumors between 4 and 6 cm were not included in the study to establish clear cut differences between groups.
  • RESULTS: Tumors were functional in 40 and 41% of cases in groups 1 and 2 respectively.
  • Fifty percent of functional tumors of group 1 were pheochromocytomas and the rest secreted aldosterone.
  • In group 2, 66% of tumors were pheochromocytomas and no aldosterone secreting tumors were found.
  • Fifty two and eight percent of tumors in Groups 1 and 2 were adenomas, respectively (p <0.001).
  • Nineteen tumors of group 2 were malignant, compared with one of group 1 (p <0.001).
  • CONCLUSIONS: The tumor size of adrenal cortical tumors may represent biological differences, suggesting two different tumor populations.
  • At time of diagnosis adrenal carcinomas are almost always larger than 6 cm.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Adrenal Glands / pathology. Carcinoma / pathology
  • [MeSH-minor] Biomarkers, Tumor. Female. Humans. Hyperplasia. Incidental Findings. Male. Middle Aged. Neoplasm Invasiveness. Retrospective Studies. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18357352.001).
  • [ISSN] 0034-9887
  • [Journal-full-title] Revista médica de Chile
  • [ISO-abbreviation] Rev Med Chil
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Chile
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


67. Gibbs KE, White A, Kaleya R: Laparoscopic management of an adrenal leiomyoma in an AIDS patient. A case report and review of the literature. JSLS; 2005 Jul-Sep;9(3):345-8
HIV InSite. treatment guidelines - Human Herpesvirus-8 .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic management of an adrenal leiomyoma in an AIDS patient. A case report and review of the literature.
  • OBJECTIVES: Laparoscopic management of adrenal masses has been well described.
  • We describe a case of an enlarging smooth muscle tumor of the adrenal gland in an acquired immunodeficiency syndrome (AIDS) patient and review the sparse literature available on this subject.
  • CASE REPORT: A 49-year-old female with AIDS complaining of vague abdominal discomfort was found to have a left adrenal mass.
  • Pathological review found the mass to be a rare adrenal leiomyoma.
  • DISCUSSION: Benign, smooth muscle tumors arising from the adrenal glands are rare.
  • A review of the literature does reveal a propensity for these tumors to occur in the immunocompromised population.
  • CONCLUSION: The ability to manage these tumors laparoscopically is of significant benefit to patients.

  • Genetic Alliance. consumer health - AIDS-HIV.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Surg Oncol. 1998 Oct;69(2):111-2 [9808515.001]
  • [Cites] World J Surg. 2000 May;24(5):579-82 [10787080.001]
  • [Cites] World J Surg. 2001 Jul;25(7):905-13 [11572032.001]
  • [Cites] Pediatr Hematol Oncol. 1991 Jul-Sep;8(3):235-41 [1742182.001]
  • [Cites] AJR Am J Roentgenol. 1992 Sep;159(3):545-6 [1503021.001]
  • [Cites] Ann Surg. 1997 May;225(5):495-501; discussion 501-2 [9193177.001]
  • [Cites] Abdom Imaging. 1994 May-Jun;19(3):259-61 [8019358.001]
  • [Cites] Clin Imaging. 1994 Oct-Dec;18(4):277-8 [8000956.001]
  • [Cites] Pediatr Pathol Lab Med. 1995 Nov-Dec;15(6):923-9 [8705202.001]
  • [Cites] AIDS. 1996 Mar;10(3):340-1 [8882677.001]
  • [Cites] Surg Endosc. 1994 Feb;8(2):135-8 [8165486.001]
  • (PMID = 16121885.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 12
  • [Other-IDs] NLM/ PMC3015615
  •  go-up   go-down


68. Trimeche Ajmi S, Chadli Chaieb M, Mokni M, Braham R, Ach K, Maaroufi A, Chaieb L: Corticomedullary mixed tumor of the adrenal gland. Ann Endocrinol (Paris); 2009 Dec;70(6):473-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corticomedullary mixed tumor of the adrenal gland.
  • Abdominal magnetic resonance imaging showed a right heterogeneous adrenal mass measuring 4 x 6 cm with mixed component of fat and adrenal tissue suggesting corticosurrenaloma.
  • In the postoperative course, the patient presented adrenal insufficiency treated with hydrocortisone hemisuccinate.
  • Histological examination showed a single tumor mass composed of an admixed population of adrenal cortical and medullary cells.
  • [MeSH-major] Adrenal Cortex / pathology. Adrenal Gland Neoplasms / diagnosis. Adrenal Medulla / pathology
  • [MeSH-minor] Adipocytes / pathology. Adrenal Insufficiency / drug therapy. Adrenal Insufficiency / etiology. Adrenalectomy / adverse effects. Adult. Amenorrhea. Androgens / blood. Chromogranin A / analysis. Cushing Syndrome. Diagnosis, Differential. Female. Hirsutism. Humans. Hydrocortisone / blood. Hypertension. Hypokalemia. Immunohistochemistry. Magnetic Resonance Imaging. Obesity. Weight Gain

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19878923.001).
  • [ISSN] 0003-4266
  • [Journal-full-title] Annales d'endocrinologie
  • [ISO-abbreviation] Ann. Endocrinol. (Paris)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Androgens; 0 / Chromogranin A; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


69. Gruschwitz T, Breza J, Wunderlich H, Junker K: Improvement of histopathological classification of adrenal gland tumors by genetic differentiation. World J Urol; 2010 Jun;28(3):329-34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Improvement of histopathological classification of adrenal gland tumors by genetic differentiation.
  • PURPOSE: There are often problems in differentiating between benign and malignant adrenal gland tumors by imaging and histopathology.
  • On account of considerable differences in the therapy and aftercare of benign and malignant adrenal tumors, correct classification of tumor type is of greatest importance.
  • METHODS: DNA was isolated from tumor areas in paraffin sections and amplified by a modified protocol for DOP-PCR.
  • After labeling of tumor-DNA and normal DNA with biotin-dUTP and digoxigenin-dUTP, respectively, comparative genomic hybridization (CGH) was carried out according to standard protocols.
  • Retrospectively, 26 (16 adenomas and 10 carcinomas) tumors of the adrenal cortex were analyzed.
  • The mean number of genetic changes per tumor was 8.7 (range 6-12) in carcinomas.
  • The benign cortical tumors present 1.6 changes (range 0-3) per tumor.
  • Only a moderate correlation between number of alterations and size of tumor was seen.
  • CONCLUSIONS: Genetic evaluation facilitates differentiation between adrenal gland tumors.
  • Genetic tests should be used in routine diagnostics of adrenal specimens.
  • Potentially, fine-needle biopsy can be established as standard diagnostics of adrenal tumors with unknown genesis.
  • [MeSH-major] Adenoma / classification. Adenoma / genetics. Adrenal Cortex Neoplasms / classification. Adrenal Cortex Neoplasms / genetics. Carcinoma / genetics
  • [MeSH-minor] Adrenalectomy / methods. Adult. Aged. Biomarkers, Tumor / analysis. Biopsy, Fine-Needle. Chromosome Aberrations. Chromosome Mapping. Cohort Studies. DNA, Neoplasm / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Polymerase Chain Reaction. Retrospective Studies. Sensitivity and Specificity. Statistics, Nonparametric. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20364258.001).
  • [ISSN] 1433-8726
  • [Journal-full-title] World journal of urology
  • [ISO-abbreviation] World J Urol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm
  •  go-up   go-down


70. Kuruba R, Gallagher SF: Current management of adrenal tumors. Curr Opin Oncol; 2008 Jan;20(1):34-46
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current management of adrenal tumors.
  • PURPOSE OF REVIEW: Adrenal tumors evoke considerable interest and diagnostic challenges.
  • This rare group of tumors includes functional tumors with a gamut of clinical presentations, as well as adrenocortical carcinoma, with its advanced disease at presentation and dismal prognosis posing additional challenge.
  • RECENT FINDINGS: Significant advances have been made in diagnostic imaging modalities for identifying malignancy risk in adrenal incidentalomas.
  • Considerable progress has occurred in understanding adrenocortical carcinoma pathogenesis from the study of genetics at the germline level in familial carcinomas, as well as at the somatic level by analyzing molecular alterations in sporadic tumors; this research supplies opportunities to develop novel therapeutic agents against a tumor with poor prognosis.
  • SUMMARY: Laparoscopic adrenalectomy has emerged as standard of care in the treatment of functional benign adenomas and nonfunctional tumors larger than 4 cm when adrenocortical carcinoma is not suspected.
  • International consensus conferences have attempted to standardize diagnostic and treatment approaches in the management of adrenal tumors; further research is necessary.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / drug therapy
  • [MeSH-minor] Adrenal Glands / pathology. Adrenal Glands / radiography. Adrenocortical Carcinoma / diagnosis. Adrenocortical Carcinoma / drug therapy. Adrenocortical Carcinoma / genetics. Chemotherapy, Adjuvant. Humans. Pheochromocytoma / diagnosis. Pheochromocytoma / drug therapy. Prognosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18043254.001).
  • [ISSN] 1040-8746
  • [Journal-full-title] Current opinion in oncology
  • [ISO-abbreviation] Curr Opin Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 68
  •  go-up   go-down


71. Katoh N, Onimaru R, Sakuhara Y, Abo D, Shimizu S, Taguchi H, Watanabe Y, Shinohara N, Ishikawa M, Shirato H: Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol; 2008 Jun;87(3):418-24
Hazardous Substances Data Bank. GOLD, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Real-time tumor-tracking radiotherapy for adrenal tumors.
  • PURPOSE: To investigate the three-dimensional movement of internal fiducial markers near the adrenal tumors using a real-time tumor-tracking radiotherapy (RTRT) system and to examine the feasibility of high-dose hypofractionated radiotherapy for the adrenal tumors.
  • CONCLUSIONS: Three-dimensional motion of a fiducial marker near the adrenal tumors was detected.
  • Hypofractionated RTRT for adrenal tumors was feasible for patients with metastatic tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / radiography. Adrenal Gland Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18439693.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 7440-57-5 / Gold
  •  go-up   go-down


72. Venkatesan AM, Locklin J, Dupuy DE, Wood BJ: Percutaneous ablation of adrenal tumors. Tech Vasc Interv Radiol; 2010 Jun;13(2):89-99
Hazardous Substances Data Bank. ETHANOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous ablation of adrenal tumors.
  • Adrenal tumors comprise a broad spectrum of benign and malignant neoplasms and include functional adrenal adenomas, pheochromocytomas, primary adrenocortical carcinoma, and adrenal metastases.
  • Percutaneous ablative approaches that have been described and used in the treatment of adrenal tumors include percutaneous radiofrequency ablation, cryoablation, microwave ablation, and chemical ablation.
  • Local tumor ablation in the adrenal gland presents unique challenges, secondary to the adrenal gland's unique anatomic and physiological features.
  • The results of clinical series employing percutaneous ablative techniques in the treatment of adrenal tumors are reviewed in this article.
  • Clinical and technical considerations unique to ablation in the adrenal gland are presented, including approaches commonly used in our practices, and risks and potential complications are discussed.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Catheter Ablation

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Oct;13(5):328-33 [14571170.001]
  • [Cites] AJR Am J Roentgenol. 2000 Apr;174(4):1031-2 [10749245.001]
  • [Cites] Radiology. 2004 Apr;231(1):143-9 [14990816.001]
  • [Cites] Technol Cancer Res Treat. 2004 Apr;3(2):181-5 [15059024.001]
  • [Cites] AJR Am J Roentgenol. 2004 Sep;183(3):575-82 [15333338.001]
  • [Cites] Lancet. 2005 Aug 20-26;366(9486):665-75 [16112304.001]
  • [Cites] Abdom Imaging. 2005 Jul-Aug;30(4):451-5 [15803226.001]
  • [Cites] Radiographics. 2005 Oct;25 Suppl 1:S69-83 [16227498.001]
  • [Cites] Oncology (Williston Park). 2005 Oct;19(11 Suppl 4):27-32 [16366376.001]
  • [Cites] Int J Oncol. 2000 Jul;17(1):181-7 [10853037.001]
  • [Cites] Surg Endosc. 2000 Oct;14(10):920-5 [11080404.001]
  • [Cites] Zhonghua Yi Xue Za Zhi (Taipei). 2000 Nov;63(11):833-7 [11155761.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):648-9 [11309443.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):995-1012 [11452074.001]
  • [Cites] Radiographics. 2001 Oct;21 Spec No:S17-35; discussion S36-9 [11598245.001]
  • [Cites] Semin Oncol. 2002 Apr;29(2):168-82 [11951215.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1486-8 [12000821.001]
  • [Cites] World J Surg. 2002 Aug;26(8):1043-7 [12045859.001]
  • [Cites] Biomed Pharmacother. 2002;56 Suppl 1:139s-144s [12487270.001]
  • [Cites] Int J Hyperthermia. 2003 Jan-Feb;19(1):89-101 [12519714.001]
  • [Cites] Curr Urol Rep. 2003 Feb;4(1):87-92 [12537947.001]
  • [Cites] Cancer. 2003 Feb 1;97(3):554-60 [12548596.001]
  • [Cites] Ann Surg Oncol. 2003 Apr;10(3):275-83 [12679313.001]
  • [Cites] Ann Ital Chir. 2002 Nov-Dec;73(6):619-22 [12820586.001]
  • [Cites] Radiographics. 2004 Oct;24 Suppl 1:S59-71 [15486250.001]
  • [Cites] Surg Gynecol Obstet. 1977 Apr;144(4):537-46 [847609.001]
  • [Cites] N Engl J Med. 1984 Nov 15;311(20):1298-303 [6149463.001]
  • [Cites] Medicine (Baltimore). 1991 Jan;70(1):46-66 [1988766.001]
  • [Cites] Clin Endocrinol (Oxf). 1991 Apr;34(4):317-30 [1879062.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Sep;75(3):826-32 [1517373.001]
  • [Cites] AJR Am J Roentgenol. 1993 Feb;160(2):321-4 [8424342.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3145-55 [8242539.001]
  • [Cites] Clin Exp Pharmacol Physiol. 1994 Apr;21(4):315-8 [7923898.001]
  • [Cites] Mayo Clin Proc. 1995 Aug;70(8):757-65 [7630214.001]
  • [Cites] Br J Surg. 1996 Apr;83(4):528-31 [8665251.001]
  • [Cites] Cancer. 1998 Jan 15;82(2):389-94 [9445197.001]
  • [Cites] Phys Med Biol. 1998 Dec;43(12):3535-47 [9869030.001]
  • [Cites] Am J Med Sci. 1953 Nov;226(5):521-4 [13104403.001]
  • [Cites] Cancer. 1950 Jan;3(1):74-85 [15405683.001]
  • [Cites] Anesth Analg. 2004 Dec;99(6):1867-9, table of contents [15562089.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Apr;90(4):2110-6 [15644401.001]
  • [Cites] Med J Aust. 2005 Aug 15;183(4):201-4 [16097921.001]
  • [Cites] J Vasc Interv Radiol. 2006 Mar;17(3):573-5 [16567684.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Jun;91(6):2027-37 [16551738.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:1-20 [17102067.001]
  • [Cites] Urology. 2007 Sep;70(3):407-11 [17905083.001]
  • [Cites] Tech Vasc Interv Radiol. 2007 Jun;10(2):132-9 [18070691.001]
  • [Cites] AJR Am J Roentgenol. 2008 Jan;190(1):105-10 [18094300.001]
  • [Cites] Radiol Clin North Am. 2008 Jan;46(1):45-64, vi [18328879.001]
  • [Cites] AJR Am J Roentgenol. 2008 May;190(5):1163-8 [18430826.001]
  • [Cites] J Urol. 2008 Aug;180(2):499-504; discussion 504 [18550123.001]
  • [Cites] Curr Opin Urol. 2008 Sep;18(5):467-73 [18670269.001]
  • [Cites] Oncologist. 2008 Jul;13(7):779-93 [18617683.001]
  • [Cites] Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):762-7 [18421499.001]
  • [Cites] J Vasc Interv Radiol. 2009 May;20(5):670-3 [19328724.001]
  • [Cites] Abdom Imaging. 2009 Sep-Oct;34(5):588-92 [18830736.001]
  • [Cites] J Vasc Interv Radiol. 2009 Nov;20(11):1483-90 [19875067.001]
  • [Cites] Cardiovasc Intervent Radiol. 2010 Jun;33(3):646-9 [19495870.001]
  • [Cites] AJR Am J Roentgenol. 2003 Aug;181(2):495-7 [12876033.001]
  • [Cites] Radiology. 1999 Nov;213(2):612-5 [10551251.001]
  • [Cites] Ann Surg Oncol. 1999 Dec;6(8):719-26 [10622498.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):637-44 [10690869.001]
  • [Cites] Radiology. 2004 Apr;231(1):225-30 [14990812.001]
  • (PMID = 20540918.001).
  • [ISSN] 1557-9808
  • [Journal-full-title] Techniques in vascular and interventional radiology
  • [ISO-abbreviation] Tech Vasc Interv Radiol
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 CL999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 3K9958V90M / Ethanol
  • [Number-of-references] 69
  • [Other-IDs] NLM/ NIHMS199588; NLM/ PMC2886030
  •  go-up   go-down


73. Plouin PF, Gimenez-Roqueplo AP, Bertagna X: [COMETE, a network for the study and management of hypersecreting adrenal tumors]. Bull Acad Natl Med; 2008 Jan;192(1):73-82; discussion 83-5
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [COMETE, a network for the study and management of hypersecreting adrenal tumors].
  • [Transliterated title] Le réseau national COMETE sur les tumeurs de la surrénale.
  • Patients with adrenal tumors are at risk of the consequences of tumor growth (including metastasis) and of hormone hypersecretion.
  • These tumors arise from tissues with distinct embryonic origins.
  • Pheochromocytomas and paragangliomas arise from the adrenal medulla and produce catecholamines; they may be benign or malignant, and sporadic or familial.
  • Adrenal adenomas and carcinomas arise from the adrenal cortex.
  • Patients with adrenocortical tumors may develop ACTH-independent hypercortisolism, mineralocorticoid excess, and androgen hypersecretion.
  • The tumors are frequently large enough to provide material for biological studies in addition to diagnostic investigations.
  • In France many patients with hypersecretory tumors are referred to the Hypertension Unit of Georges Pompidou European Hospital, and to the Department of Endocrinology at Cochin Hospital, Paris.
  • In 1993, the heads of these departments created the COMETE network (COrtico et MEdullo-surrénale, les Tumeurs Endocrines).
  • The overall objective of COMETE is to promote basic and clinical research into adrenal tumors.
  • This implies - in cross-sectional studies: collecting adrenal tumors, maintaining a collection of tumor and leukocyte DNA samples, keeping a computerized record of relevant biological and clinical data, and distributing biological samples and bioclinical information anonymously to collaborating research laboratories; in prospective studies: ensuring indefinite follow-up of patients with tumors at risk of malignancy or recurrence, which means establishing and maintaining a cohort of patients with large adrenocortical tumors or carcinomas anda cohort of patients with pheochromocytomas or paragangliomas.
  • [MeSH-major] Adrenal Gland Neoplasms / metabolism. Societies, Medical / organization & administration

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18663983.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


74. Tsuru N, Ushiyama T, Suzuki K: Laparoscopic adrenalectomy for primary and secondary malignant adrenal tumors. J Endourol; 2005 Jul-Aug;19(6):702-8; discussion 708-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy for primary and secondary malignant adrenal tumors.
  • Laparoscopic adrenalectomy is unanimously recognized as the gold standard for the treatment of adrenal tumors, but it is not indicated for tumors of any size when invasion of the surrounding tissues is clearly detected by preoperative imaging.
  • Although laparoscopic adrenalectomy for metastatic adrenal malignancy is a feasible procedure, in the case of primary adrenal malignancy, it should be done very carefully.
  • When laparoscopic surgery is performed for adrenal tumors >6 cm or for tumors that are considered potentially malignant after preoperative imaging or endocrine studies, the operation should be performed only by a highly skilled laparoscopic surgeon.
  • It is also important to inform the patient and family that the tumors may be malignant and that conversion to open surgery could be necessary.
  • The surgeon must create a sufficiently wide working space, remove the tumor and surrounding fat en bloc, and never grasp the tumor or adrenal tissue.
  • The ultrasonically activated scalpel or ultrasonic endoaspirator should be carefully handled so that it does not touch the tumor surface because this will create a risk of tumor-cell dissemination.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16053359.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 42
  •  go-up   go-down


75. Wang H, Zhou FJ, Qin ZK, Han H, Liu ZW: [Laparoscopic surgery for benign adrenal tumor: a report of 10 cases]. Ai Zheng; 2005 Jan;24(1):76-8
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic surgery for benign adrenal tumor: a report of 10 cases].
  • BACKGROUND & OBJECTIVE: Adrenalectomy is a standard treatment for benign adrenal tumors.
  • Conventional open operation usually results in bigger incisions, more blood loss, and long hospital stay to patients; while laparoscopic approaches could make up above shortcomings, which is used to resect benign adrenal tumors gradually.
  • METHODS: Clinical data of 10 patients with benign adrenal tumors undergone laparoscopic adrenalectomy were retrospectively analyzed to summarize the experiences and techniques in laparoscopic surgery.
  • RESULTS: Of the 10 patients, 9 had tumors successfully resected by laparoscopic adrenalectomy with no severe postoperative complication; 1 switched to receive open surgery during operation, and had mild postoperative corticoadrenal insufficiency.
  • CONCLUSION: Laparoscopic surgery for treatment of benign adrenal tumors has the advantages of minimal invasion, safety, and efficiency, and may be a primary therapeutic option for benign adrenal tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy. Pheochromocytoma / surgery

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15642205.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


76. Opocher G, Schiavi F, Cicala MV, Patalano A, Mariniello B, Boaretto F, Zovato S, Pignataro V, Macino B, Negro I, Mantero F: Genetics of adrenal tumors. Minerva Endocrinol; 2009 Jun;34(2):107-21
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetics of adrenal tumors.
  • Endocrinology pioneered the development of molecular medicine, but also the study of adrenal tumors had a great impact in this field.
  • Particularly important was the detection of genetics of tumors derived from the adrenal medulla, as well as that of those derived from the sympathetic and parasympathetic paraganglia.
  • Less well understood is the genetics of adrenal cortex tumors, in particular adrenocortical carcinoma, a rare and particularly aggressive disease.
  • There are only a few examples of hereditary transmission of adrenocortical carcinoma, but the analysis of low penetrance genes by genome wide association study may enable us to discover new genetic mechanisms responsible for adrenocortical-derived tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Biomarkers, Tumor / genetics. Mutation. Pheochromocytoma / genetics
  • [MeSH-minor] Adrenal Cortex Neoplasms / genetics. Adrenocortical Carcinoma / genetics. Genetic Predisposition to Disease. Genomics. Humans. Neoplasm Proteins / genetics. Paraganglioma / genetics

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19471236.001).
  • [ISSN] 0391-1977
  • [Journal-full-title] Minerva endocrinologica
  • [ISO-abbreviation] Minerva Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  • [Number-of-references] 81
  •  go-up   go-down


77. Iwase K, Nagasaka A, Kato K, Itoh A, Jimbo S, Hibi Y, Kobayashi N, Yamamoto H, Seko T, Miura K: Cu/Zn- and Mn-superoxide dismutase distribution and concentration in adrenal tumors. J Surg Res; 2006 Sep;135(1):150-5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cu/Zn- and Mn-superoxide dismutase distribution and concentration in adrenal tumors.
  • The tissue distribution of Cu/Zn- and Mn-superoxide dismutases (SOD) in adrenal tumors was studied by an immunohistochemical technique, and the concentrations of both SODs were measured by a sensitive sandwich enzyme immunoassay technique.
  • In the normal adrenal gland, both Cu/Zn- and Mn-SODs were localized predominantly in the reticular zone of the cortex.
  • In different adrenal tumors, the localization of both stained SODs reflected the origin of the tumor cell.
  • The concentrations of both SODs in the tissues of medullary tumors were lower than those in the normal adrenal gland and adrenocortical adenomas.
  • The concentration of Cu/Zn-SOD in the tumor tissue of Cushing's syndrome adenoma was higher, and that of Mn-SOD was lower than the concentrations in the normal adrenal gland.
  • The ratio of the tissue concentrations of Mn-SOD to Cu/Zn-SOD was lower in adrenal medullary tumors and Cushing's syndrome adenomas than in the normal adrenal gland and primary aldosteronism adenomas, indicating the predominance of Cu/Zn-SOD in the former, and Mn-SOD in the latter.
  • These data suggest that the localization of Cu/Zn- and Mn-SODs in adrenal tissues reflects the specificity of the adrenal cells that produce the tissue-specific hormones.
  • An investigation of changes in these enzymes in adrenal tumors may also provide useful information on adrenal tumor cell differentiation.
  • [MeSH-major] Adrenal Cortex / enzymology. Adrenal Cortex Neoplasms / metabolism. Adrenocortical Adenoma / metabolism. Superoxide Dismutase / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16780879.001).
  • [ISSN] 0022-4804
  • [Journal-full-title] The Journal of surgical research
  • [ISO-abbreviation] J. Surg. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.15.1.1 / Superoxide Dismutase
  •  go-up   go-down


78. Gross MD, Gauger PG, Djekidel M, Rubello D: The role of PET in the surgical approach to adrenal disease. Eur J Surg Oncol; 2009 Nov;35(11):1137-45
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of PET in the surgical approach to adrenal disease.
  • BACKGROUND: Appropriate surgical approach to diseases of the adrenal requires a diagnosis sufficient to determine the biochemical status of adrenal dysfunction and anatomic evaluation sufficient to differentiate unilateral from bilateral disease, intra-adrenal from extra-adrenal neoplasm, adrenal tumor recurrence or adrenal metastases.
  • High resolution computed tomography (CT) and magnetic resonance have been the primary imaging modalities for the evaluation of anatomy, while scintigraphic studies have played a secondary role in diagnosis.
  • The recent availability of functional imaging provided by positron emission tomography (PET) with radiopharmaceuticals designed to depict substrate precursor uptake, cellular metabolism or receptor binding in neoplasms and CT as a single modality, hybrid PET/CT, to directly correlate function and anatomy has had a significant impact upon the diagnostic and therapeutic approach to many cancers and has been applied to adrenal disease with some early success that we describe in this review.
  • METHODS: In addition to the authors' experience, a search of Medline and PubMed databases was performed using search terms: 'adrenal scintigraphy', 'positron tomography', 'computed tomography', 'adrenal surgery', 'adrenal mass', '(18)F-fluorodeoxyglucose', 'adrenal carcinoma', 'adrenal medulla' and 'pheochromocytoma'.
  • CONCLUSIONS: Present PET radiopharmaceuticals and their use in hybrid PET/CT have demonstrated efficacy in the preoperative and follow-up evaluation of neoplasms of the adrenal cortex and medulla that hopefully will continue to improve with the development of newer tracers that continue to exploit unusual characteristics of the adrenals.
  • [MeSH-major] Adrenal Gland Neoplasms / radionuclide imaging. Adrenal Gland Neoplasms / surgery. Radiopharmaceuticals. Tomography, Emission-Computed
  • [MeSH-minor] Diagnosis, Differential. Humans. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19243910.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals
  • [Number-of-references] 75
  •  go-up   go-down


79. Sandgren J, Andersson R, Rada-Iglesias A, Enroth S, Akerstrom G, Dumanski JP, Komorowski J, Westin G, Wadelius C: Integrative epigenomic and genomic analysis of malignant pheochromocytoma. Exp Mol Med; 2010 Jul 31;42(7):484-502
Hazardous Substances Data Bank. L-Lysine .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epigenomic and genomic changes affect gene expression and contribute to tumor development.
  • Furthermore, genomic aberrations such as DNA copy number changes are common events in tumors.
  • Pheochromocytoma is a rare endocrine tumor of the adrenal gland that mostly occurs sporadic with unknown epigenetic/genetic cause.
  • The integrated analysis of the tumor expression levels, in relation to normal adrenal medulla, indicated that either histone modifications or chromosomal alterations, or both, have great impact on the expression of a substantial fraction of the genes in the investigated sample.
  • Candidate tumor suppressor genes identified with decreased expression, a H3K27me3 mark and/or in regions of deletion were for instance TGIF1, DSC3, TNFRSF10B, RASSF2, HOXA9, PTPRE and CDH11.
  • Our approach to associate histone methylations and DNA copy number changes to gene expression revealed apparent impact on global gene transcription, and enabled the identification of candidate tumor genes for further exploration.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Adrenal Gland Neoplasms / pathology. Epigenesis, Genetic. Genome, Human / genetics. Genomics. Pheochromocytoma / genetics. Pheochromocytoma / pathology
  • [MeSH-minor] Female. Gene Dosage / genetics. Gene Expression Regulation, Neoplastic. Gene Regulatory Networks / genetics. Histones / metabolism. Humans. Lysine / metabolism. Methylation. Protein Processing, Post-Translational. Tumor Suppressor Proteins / genetics. Tumor Suppressor Proteins / metabolism

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cytokine Growth Factor Rev. 2008 Apr;19(2):111-20 [18308616.001]
  • [Cites] Cell Stem Cell. 2007 Sep 13;1(3):286-98 [18371363.001]
  • [Cites] Cell Stem Cell. 2007 Sep 13;1(3):299-312 [18371364.001]
  • [Cites] Cancer Res. 2008 Apr 15;68(8):2641-51 [18413731.001]
  • [Cites] BMB Rep. 2008 Apr 30;41(4):294-9 [18452649.001]
  • [Cites] Clin Cancer Res. 2008 May 1;14(9):2551-9 [18451216.001]
  • [Cites] Nat Genet. 2008 Jun;40(6):741-50 [18488029.001]
  • [Cites] Nat Genet. 2008 Jul;40(7):897-903 [18552846.001]
  • [Cites] Nature. 2008 Aug 7;454(7205):766-70 [18600261.001]
  • [Cites] Carcinogenesis. 2008 Jul;29(7):1312-8 [18310659.001]
  • [Cites] Endocr Relat Cancer. 2008 Sep;15(3):777-86 [18499731.001]
  • [Cites] Mutat Res. 2008 Dec 1;647(1-2):21-9 [18723033.001]
  • [Cites] Science. 2000 Feb 4;287(5454):848-51 [10657297.001]
  • [Cites] Nat Genet. 2000 Jul;25(3):333-7 [10888885.001]
  • [Cites] Mamm Genome. 2000 Sep;11(9):767-73 [10967136.001]
  • [Cites] Nature. 1993 Jun 3;363(6428):458-60 [8099202.001]
  • [Cites] Cancer Res. 1993 Sep 15;53(18):4169-71 [8364910.001]
  • [Cites] EMBO J. 1998 Jan 2;17(1):215-22 [9427755.001]
  • [Cites] Endocr Relat Cancer. 2004 Dec;11(4):897-911 [15613462.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Mar;42(3):260-8 [15609347.001]
  • [Cites] Cell. 2005 Jan 28;120(2):169-81 [15680324.001]
  • [Cites] J Surg Oncol. 2005 Mar 1;89(3):193-201 [15719371.001]
  • [Cites] Endocr Relat Cancer. 2005 Mar;12(1):161-72 [15788647.001]
  • [Cites] Oncogene. 2005 Jun 2;24(24):3987-94 [15806169.001]
  • [Cites] Sci Signal. 2008;1(46):pe49 [19018012.001]
  • [Cites] Science. 1993 May 28;260(5112):1317-20 [8493574.001]
  • [Cites] Immunity. 2009 Jan 16;30(1):155-67 [19144320.001]
  • [Cites] Oncogene. 2009 Feb 19;28(7):994-1004 [19079341.001]
  • [Cites] PLoS One. 2009;4(3):e4687 [19262738.001]
  • [Cites] Cancer Cell. 2009 Apr 7;15(4):328-40 [19345331.001]
  • [Cites] J Gastroenterol. 2009;44(4):305-12 [19267258.001]
  • [Cites] Epigenetics. 2009 Feb 16;4(2):107-13 [19276669.001]
  • [Cites] Endocr Relat Cancer. 2009 Jun;16(2):505-13 [19153209.001]
  • [Cites] Immunity. 2009 Jun 19;30(6):912-25 [19523850.001]
  • [Cites] Endocr Relat Cancer. 2010 Sep;17(3):561-79 [20410162.001]
  • [Cites] Nat Protoc. 2009;4(1):44-57 [19131956.001]
  • [Cites] Breast Cancer Res. 2005;7(5):R669-80 [16168112.001]
  • [Cites] Blood. 2005 Nov 1;106(9):3214-22 [16051735.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Jan;45(1):83-93 [16215979.001]
  • [Cites] Hum Mol Genet. 2005 Nov 15;14(22):3435-47 [16221759.001]
  • [Cites] Int J Cancer. 2006 Mar 1;118(5):1159-64 [16161042.001]
  • [Cites] Nucleic Acids Res. 2006 Jan 1;34(Database issue):D632-6 [16381948.001]
  • [Cites] Oncogene. 2006 Mar 16;25(12):1733-42 [16278676.001]
  • [Cites] Bioinformatics. 2006 Apr 15;22(8):1024-6 [16455749.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Jul;45(7):656-67 [16575877.001]
  • [Cites] Genome Res. 2006 Jul;16(7):890-900 [16751344.001]
  • [Cites] J Urol. 2006 Sep;176(3):891-5 [16890646.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:541-56 [17102123.001]
  • [Cites] Nat Genet. 2006 Dec;38(12):1386-96 [17099711.001]
  • [Cites] Nat Genet. 2007 Feb;39(2):232-6 [17200670.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5527-32 [17369352.001]
  • [Cites] Endocr Relat Cancer. 2007 Mar;14(1):125-34 [17395981.001]
  • [Cites] Cell. 2007 May 18;129(4):823-37 [17512414.001]
  • [Cites] Br J Cancer. 2007 Jun 18;96(12):1783-7 [17519903.001]
  • [Cites] Cell. 2007 Jul 13;130(1):77-88 [17632057.001]
  • [Cites] Mol Endocrinol. 2007 Aug;21(8):1835-46 [17505060.001]
  • [Cites] Nature. 2007 Aug 2;448(7153):553-60 [17603471.001]
  • [Cites] Oncol Rep. 2007 Sep;18(3):673-7 [17671718.001]
  • [Cites] Virchows Arch. 2007 Nov;451(5):959-66 [17846785.001]
  • [Cites] Cancer Res. 2007 Nov 15;67(22):10657-63 [18006806.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Dec;92(12):4865-72 [17878247.001]
  • [Cites] Nucleic Acids Res. 2008 Jan;36(Database issue):D773-9 [18086701.001]
  • [Cites] Nat Genet. 2000 Nov;26(3):268-70 [11062460.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Dec;85(12):4568-74 [11134110.001]
  • [Cites] Lancet. 2001 Apr 14;357(9263):1181-2 [11323050.001]
  • [Cites] Am J Hum Genet. 2001 Jul;69(1):49-54 [11404820.001]
  • [Cites] J Cell Biol. 2001 Jul 23;154(2):345-54 [11470823.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] Nat Rev Cancer. 2002 Oct;2(10):777-85 [12360280.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8 [12297621.001]
  • [Cites] Hum Mol Genet. 2002 Dec 1;11(25):3221-9 [12444106.001]
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Endocr Rev. 2003 Aug;24(4):539-53 [12920154.001]
  • [Cites] J Natl Cancer Inst. 2003 Aug 20;95(16):1196-204 [12928344.001]
  • [Cites] Endocr Pathol. 2003 Winter;14(4):329-50 [14739490.001]
  • [Cites] Oncogene. 2004 Apr 22;23(19):3487-94 [15007382.001]
  • [Cites] Genes Dev. 2004 Jul 1;18(13):1592-605 [15231737.001]
  • [Cites] Nat Cell Biol. 2004 Aug;6(8):731-40 [15235609.001]
  • [Cites] Mod Pathol. 2004 Sep;17(9):1119-28 [15167935.001]
  • [Cites] J Natl Cancer Inst. 2004 Aug 18;96(16):1208-19 [15316056.001]
  • [Cites] Mol Cancer Res. 2004 Sep;2(9):495-503 [15383628.001]
  • [Cites] Genome Biol. 2004;5(10):R80 [15461798.001]
  • [Cites] Cancer Res. 1992 Mar 1;52(5):1364-8 [1737399.001]
  • [Cites] Genes Chromosomes Cancer. 1992 Jun;4(4):337-42 [1377942.001]
  • [Cites] J Biol Chem. 1992 Jul 25;267(21):15252-7 [1634555.001]
  • [Cites] Hum Mutat. 2008 Mar;29(3):398-408 [18058796.001]
  • [Cites] Bioinformatics. 2008 Mar 15;24(6):751-8 [18204059.001]
  • [Cites] Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):37-42 [18359978.001]
  • (PMID = 20534969.001).
  • [ISSN] 2092-6413
  • [Journal-full-title] Experimental & molecular medicine
  • [ISO-abbreviation] Exp. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Histones; 0 / Tumor Suppressor Proteins; K3Z4F929H6 / Lysine
  • [Other-IDs] NLM/ PMC2912476
  •  go-up   go-down


80. Gazymov MM, Filipov DS: [Adrenal tumors: topical diagnosis and surgical outcomes]. Urologiia; 2005 Sep-Oct;(5):9-12
MedlinePlus Health Information. consumer health - High Blood Pressure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal tumors: topical diagnosis and surgical outcomes].
  • A total of 128 adrenalectomies were made for catechol-producing tumor (n = 69), mineralocorticism (n = 27), primary and metastatic adrenal cancer (n = 20), other tumors (n = 12).
  • If cancer involves the upper segment of the kidney, the tumor often invades the adrenal.
  • Therefore, pre- and intraoperative search for adrenal tumor must be made.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / surgery. Adrenalectomy. Hypertension / surgery

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16281831.001).
  • [ISSN] 1728-2985
  • [Journal-full-title] Urologii︠a︡ (Moscow, Russia : 1999)
  • [ISO-abbreviation] Urologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


81. Hamamatsu A, Arai T, Iwamoto M, Kato T, Sawabe M: Adenomatoid tumor of the adrenal gland: case report with immunohistochemical study. Pathol Int; 2005 Oct;55(10):665-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomatoid tumor of the adrenal gland: case report with immunohistochemical study.
  • Adrenal adenomatoid tumor (AT) is a recently recognized disease with marked male predominance.
  • Herein is presented a case of adrenal AT incidentally found in a 30-year-old man and results of immunohistochemical examination of the tumor.
  • The left adrenal gland, weighing 17 g, contained a mass measuring 3 x 2.5 x 2.5 cm in the cortical tissue.
  • Cut surface showed a relatively well-circumscribed firm tumor with a white solid appearance.
  • Histologically, the tumor had the typical appearance of AT described in the genital tract.
  • Immunohistochemically, the tumor cells were positive for calretinin, D2-40, WT1, mesothelial cell antigen, CA125, thrombomodulin, vimentin and cytokeratins (stained by AE1 + AE3, OV-TL 12/30, CAM5.2 and MNF116), and negative for endothelial markers (CD31, CD34 and factor VIII-related antigen) and CD56.
  • CD56-positive adrenocortical cells were diffusely scattered in the tumor, especially in its periphery.
  • These findings confirm mesothelial origin of the tumor and suggest that this tumor has little relation to sex hormone despite male predominance.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Adrenocortical Adenoma / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Coronary Thrombosis / mortality. Coronary Thrombosis / pathology. Fatal Outcome. Humans. Immunoenzyme Techniques. Male

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16185299.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


82. Phitayakorn R, McHenry CR: Laparoscopic and selective open resection for adrenal and extraadrenal neuroendocrine tumors. Am Surg; 2008 Jan;74(1):37-42
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic and selective open resection for adrenal and extraadrenal neuroendocrine tumors.
  • Laparoscopic resection is preferred for most adrenal tumors.
  • From 1996 to 2007, 54 consecutive patients who underwent resection of an adrenal tumor or extraadrenal pheochromocytoma were reviewed to determine the outcome of laparoscopic resection and the rate of conversion and indications for open resection.
  • Laparoscopic adrenalectomy was initiated in 42 patients, three (7.3%) of whom underwent conversion to an open approach because of bleeding from an accessory vein (one), tumor invasion (one), or adhesions (one) (median American Society of Anesthesiologists score = 2, estimated blood loss = 186 +/- 235 mL, size = 5 +/- 3 cm).
  • Open resection was performed in 12 patients, six at the time of another procedure, three for pheochromocytoma of the organs of Zuckerkandl, two for bilateral adrenalectomy, and one for tumor invasion (median American Society of Anesthesiologists score = 3, estimated blood loss = 1525 +/- 978 mL, size = 8 +/- 4 cm).
  • When unrecognized, an accessory right adrenal vein may be a source of significant bleeding requiring conversion to an open approach.
  • Open resection is indicated for tumor invasion, for extraadrenal pheochromocytoma, when laparoscopic resection cannot be performed safely, and for concomitant open procedures.
  • [MeSH-major] Adenoma / surgery. Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy. Pheochromocytoma / surgery

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18274426.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Hiroi N, Yanagisawa R, Yoshida-Hiroi M, Endo T, Kawase T, Tsuchida Y, Toyama K, Shibuya K, Nakata K, Yoshino G: Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma. J Endocrinol Invest; 2006 Jun;29(6):551-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma.
  • A 56-yr-old man was admitted to our university hospital for severe back pain one month after a resection for lung adenocarcinoma (stage IIIA) without evidence of the adrenal mass.
  • Computed tomography (CT) of the abdomen showed bilateral bleeding of adrenal tumors.
  • Core-needle biopsy was performed on the right adrenal tumor and revealed adenocarcinoma cells mimicking a primary lung tumor previously examined.
  • We diagnosed retroperitoneal hemorrhage due to bilateral adrenal gland metastasis from lung adenocarcinoma with adrenal insufficiency.
  • Adrenal metastases most commonly originate from a primary lung tumor, followed by stomach, esophagus and liver/bile ducts.
  • Bilateral adrenal metastases were noted in approximately half of all adrenal metastases patients.
  • Clinically significant adrenal hemorrhage by metastasis is exceedingly rare and non-specific symptoms, such as abdominal, chest or back pain, nausea and vomiting, confusion, weakness, hypotension, shock and high fever, are often observed in these patients.
  • We present a case of massive retroperitoneal hemorrhage and adrenal insufficiency due to adrenal gland metastasis from adenocarcinoma of lung.
  • [MeSH-major] Adenocarcinoma / secondary. Adrenal Gland Neoplasms / secondary. Adrenal Insufficiency / etiology. Hemorrhage / etiology. Lung Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16840834.001).
  • [ISSN] 0391-4097
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


84. Nomura M, Sasano H, Okada Y, Watanabe T, Sakamoto S, Sakiyama Y, Sakamoto R, Abe I, Horiuchi T, Yanase T, Takayanagi R: Adrenal failure caused by a retroperitoneal malignant mesothelioma. Intern Med; 2009;48(24):2109-14
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal failure caused by a retroperitoneal malignant mesothelioma.
  • A 62-year-old man presented with clinical signs of acute abdominal pain and adrenal insufficiency.
  • Computerized tomographic scans revealed bilateral adrenal tumors and the left adrenal tumor was surgically resected.
  • The patient was found to have retroperitoneal mesothelioma presenting as bilateral metastatic adrenal tumors, which were well controlled by systemic chemotherapy with CDDP and 5-FU.
  • This case appears to be the first reported case in the literature of adrenal failure due to bilateral adrenal infiltration caused by retroperitoneal malignant mesothelioma.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Insufficiency / etiology. Mesothelioma / secondary. Retroperitoneal Neoplasms / pathology


85. Koizumi K, Mizusawa H, Oguchi T, Domen T, Kato H: [Adult Wilms' tumor mimicking adrenal tumor: case report]. Hinyokika Kiyo; 2008 Sep;54(9):603-6
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adult Wilms' tumor mimicking adrenal tumor: case report].
  • A 33-year-old woman was referred to our hospital for further examination of a right adrenal mass 4.5 cm in diameter.
  • Computed tomography, magnetic resonance image and angiograpy demonstrated non-functioning adrenal tumor.
  • Right nephrectomy was performed, because the tumor adhered firmly to the upper pole of the right kidney.
  • The pathological diagnosis was nephroblastoma (nephroblastic type, complex subtype).
  • Postoperative chemotherapy was started for stage III Wilms' tumor.
  • [MeSH-major] Kidney Neoplasms / diagnosis. Wilms Tumor / diagnosis
  • [MeSH-minor] Adrenal Gland Neoplasms. Adult. Antineoplastic Combined Chemotherapy Protocols / adverse effects. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Dactinomycin / administration & dosage. Diagnosis, Differential. Diagnostic Imaging. Female. Humans. Nephrectomy. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Wilms' tumor.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Wilms Tumor.
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18975574.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine
  •  go-up   go-down


86. Lu J, Huang Y, Hong K, Liu YQ, Tian XJ, Zhang SD, Wang GL, Liu L, Ma LL: [Retroperitoneal laparoscopic adrenalectomy for larger adrenal tumor]. Beijing Da Xue Xue Bao; 2010 Aug 18;42(4):454-7
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Retroperitoneal laparoscopic adrenalectomy for larger adrenal tumor].
  • OBJECTIVE: To evaluate the feasibility and safety of retroperitoneal laparoscopic adrenalectomy for larger adrenal tumor.
  • METHODS: A retrospective cohort study of patients who underwent retroperitoneal laparoscopic adrenalectomy in a single unit from July 2004 to December 2008 was undertaken, in which 53 cases were divided into 2 groups according to size as estimated by group A [n=13; age: 45+/-18 years; size: (7.6+/-1.2) cm, maximum diameter of tumor larger than 6 cm] and group B [n=40; age: (49+/-12) years; size: (4.0+/-0.9) cm, between 3 and 6 cm].
  • The pathology of most tumors in group A included medullary lipoma(30.8%), pheochromocytoma(23%) and ganglioneuroma(23%), the others included adenoma(32.5%), pheochromocytoma(25%) and ganglioneuroma(17.5%) in group B.
  • CONCLUSION: Retroperitoneal laparoscopic adrenalectomy has best value in patients with larger adrenal tumor and it is a minimally invasive and safe procedure for skillful surgeons in the treatment of tumor size larger than 6 cm.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy / methods. Lipoma / surgery. Pheochromocytoma / surgery

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20721263.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


87. Silvio Estaba L, Madrazo González Z, Pujol Gebelli J, Masdevall Noguera C, Rafecas Renau A, Moreno Llorente P: [Laparoscopic adrenalectomy for suspected isolated adrenal metastasis]. Cir Esp; 2007 Apr;81(4):197-201
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic adrenalectomy for suspected isolated adrenal metastasis].
  • [Transliterated title] Adrenalectomía laparoscópica por sospecha de metástasis adrenal solitaria.
  • INTRODUCTION: Isolated adrenal metastasis is uncommon.
  • The aim of this study was to evaluate the indications, diagnosis and utility of laparoscopic adrenalectomy (LA) in patients with isolated adrenal metastasis.
  • PATIENTS AND METHOD: A prospective study was conducted in patients with current or previous tumoral disease and with isolated adrenal metastasis.
  • Fifteen LA were performed (one patient was found to have an inoperable tumor at surgery).
  • Histopathological analysis revealed non-tumoral disease in two patients.
  • The most common metastatic disease was non-small cell lung carcinoma (NSCLC) (10 patients), followed by colorectal cancer metastasis (two patients).
  • The mean tumor size was 4.7 cm and was 3.8 cm on computed tomography (p = 0.09).
  • The disease-free interval (DFI) in the NSCLC group was shorter than that in the remaining tumors (p = 0.17).
  • At the end of the study, five patients were alive: two were disease free, one had recurrent disease, one had margin involvement and one was awaiting resection of the primary tumor.
  • CONCLUSIONS: LA for metastasis can be performed without oncological disadvantage and should be offered to patients with resectable disease, a DFI > 6 months, and a tumoral size that allows laparoscopic resection.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy. Laparoscopy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17403355.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


88. Misseri R: Adrenal surgery in the pediatric population. Curr Urol Rep; 2007 Jan;8(1):89-94
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal surgery in the pediatric population.
  • Adrenal tumors in children may be benign or malignant.
  • In addition, both benign and malignant tumors may be hormonally active, leading to hypertension, metabolic crises, and endocrinopathies.
  • These tumors may be found incidentally or secondary to signs and symptoms of the aforementioned disorders.
  • Both a metabolic and a radiographic work-up are required before treatment of an adrenal tumor.
  • The primary therapy for most adrenal lesions is surgical, though some are treated medically or require chemotherapy before excision.
  • Laparoscopy has become the surgical approach of choice in both adult and pediatric patients with localized disease.
  • Open surgical approaches remain necessary in patients with extensive locally invasive or metastatic disease.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods
  • [MeSH-minor] Adrenal Gland Diseases / mortality. Adrenal Gland Diseases / pathology. Adrenal Gland Diseases / surgery. Adrenal Glands / embryology. Adrenal Glands / physiopathology. Age Factors. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Laparoscopy / methods. Male. Neuroblastoma / mortality. Neuroblastoma / pathology. Neuroblastoma / surgery. Pheochromocytoma / mortality. Pheochromocytoma / pathology. Pheochromocytoma / surgery. Risk Assessment. Survival Analysis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17239322.001).
  • [ISSN] 1534-6285
  • [Journal-full-title] Current urology reports
  • [ISO-abbreviation] Curr Urol Rep
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 39
  •  go-up   go-down


89. Araujo Júnior E, Sanchez Ayub E, Costa Santos EM, Moraes DJ, Rodrigues Pires C, Filho Sebastião MZ: [Prenatal ultrasound diagnosis of adrenal neuroblastoma]. Ginecol Obstet Mex; 2005 Aug;73(8):451-5
MedlinePlus Health Information. consumer health - Neuroblastoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prenatal ultrasound diagnosis of adrenal neuroblastoma].
  • [Transliterated title] Diagnóstico prenatal ultrasonográfico de neuroblastoma adrenal.
  • Neuroblastoma is the most frequent solid malignant tumor in the neonatal period; however, its diagnosis is very difficult in the prenatal one.
  • This kind of tumor has a high morbidity and mortality rate due to the metastatic risk.
  • Its prognosis depends on the affected area, on the extension of the tumor, and on the associated abnormalities.
  • The antenatal ultrasound diagnosis is possible by finding a mixed mass in the adrenal gland.
  • We report a case of a bilateral adrenal neuroblastoma diagnosed by antenatal ultrasonography at the 29th week of gestation.
  • We describe the principal findings and show the contribution of the tridimensional ultrasound on the relationship of the tumor with the nearby structures.
  • [MeSH-major] Adrenal Gland Neoplasms / ultrasonography. Fetal Diseases / ultrasonography. Neuroblastoma / ultrasonography. Ultrasonography, Prenatal


90. Toba A, Tamura Y, Osajima Y, Kinbara Y, Sato M, Yamaga R, Hashimoto R, Mori S, Miyakoshi S, Ota M, Ito H, Araki A: [A case of nasal NK/T cell lymphoma presenting with bilateral giant adrenal tumors]. Nihon Ronen Igakkai Zasshi; 2008 Nov;45(6):660-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of nasal NK/T cell lymphoma presenting with bilateral giant adrenal tumors].
  • Abdominal echogram showed bilateral adrenal swelling (left adrenal 90x80 mm, right adrenal 50x20 mm) and she was admitted to the hospital for further examination.
  • A tumor was also found inside nasal cavity by enhanced computed tomography (CT), and abnormal uptake in the nasal cavity and adrenal gland was shown in gallium scintigraphy.
  • Biopsy of the nasal tumor revealed nasal natural killer or thymus-derived (NK/T) cell lymphoma.
  • After THP-COP chemotherapy regimen, both the nasal and adrenal tumors decreased in size.
  • Since she had a high level of plasma ACTH (158.0 pg/ml) and normal serum cortisol (14.6 microg/dl), partial adrenal insufficiency was suspected.
  • In addition, since her cortisol circadian rhythm was lost and cortisol levels were not completely suppressed by the 1 mg and 8 mg dexamethasone test, she met the criteria of the diagnosis of preclinical Cushing syndrome.
  • NK/T cell lymphoma with giant adrenal tumor is extremely rare, but should be considered as one of the differential diagnoses of bilateral adrenal tumor.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Lymphoma, Extranodal NK-T-Cell / complications. Nose Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19179800.001).
  • [ISSN] 0300-9173
  • [Journal-full-title] Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
  • [ISO-abbreviation] Nihon Ronen Igakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


91. Zhang Y, Li H: Primitive neuroectodermal tumors of adrenal gland. Jpn J Clin Oncol; 2010 Aug;40(8):800-4
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primitive neuroectodermal tumors of adrenal gland.
  • OBJECTIVES: To analyze the clinical and pathological characteristics of adrenal primitive neuroectodermal tumors for a better understanding of the disease.
  • METHODS: A retrospective analysis of four cases of adrenal primitive neuroectodermal tumors (two male, two female; age 21-30, average 24) was made.
  • Among the four patients, one refused to receive treatment after definitiver diagnosis through needle biopsy, three received surgical treatments and their post-operative pathological exams all confirmed the diagnoses of primitive neuroectodermal tumors.
  • CONCLUSIONS: Adrenal primitive neuroectodermal tumor is a very rare tumor.
  • It has non-specific clinical or imaging manifestation and its diagnosis is mostly based on pathological examinations.
  • The tumor is fast-developing, highly malignant with poor prognosis.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / pathology. Neuroectodermal Tumors / diagnosis. Neuroectodermal Tumors / pathology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20430773.001).
  • [ISSN] 1465-3621
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


92. Hamada S, Ito K, Tobe M, Otsuki H, Hama Y, Kato Y, Sugiura Y, Kaji T, Asano T, Hayakawa M: Bilateral adrenal leiomyosarcoma treated with multiple local therapies. Int J Clin Oncol; 2009 Aug;14(4):356-60
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral adrenal leiomyosarcoma treated with multiple local therapies.
  • A 62-year-old woman presented with right flank pain, and computed tomography (CT) showed bilateral adrenal tumors (right, 8 cm; left, 4 cm).
  • There were no abnormal findings on physical examination, and adrenal hormone levels in serum and urine were within normal limits.
  • Radiological studies showed a right adrenal tumor with intratumoral hemorrhage, a cystic tumor in the left adrenal gland, and no sign of distant metastasis.
  • Because laboratory tests showed normal levels of adrenal hormones, we considered the tumors to be nonfunctioning adrenal tumors.
  • The right adrenal tumor was surgically removed because it was thought to be malignant, and histological examination revealed that it was a leiomyosarcoma.
  • Because the left adrenal tumor grew rapidly despite two courses of the chemotherapy, it too was surgically removed.
  • Sixteen months after the right adrenalectomy, the patient died due to systemic spread of the disease.
  • Multiple local treatments including RFA, radiotherapy, and resection were effective for the local control of metastatic lesions of adrenal leiomyosarcoma.
  • [MeSH-major] Adrenal Gland Neoplasms / therapy. Adrenalectomy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Catheter Ablation. Leiomyosarcoma / therapy
  • [MeSH-minor] Adult. Aged. Biopsy. Bone Neoplasms / secondary. Bone Neoplasms / therapy. Chemotherapy, Adjuvant. Fatal Outcome. Female. Humans. Kidney Neoplasms / secondary. Kidney Neoplasms / therapy. Liver Neoplasms / secondary. Liver Neoplasms / therapy. Male. Middle Aged. Pancreatic Neoplasms / secondary. Pancreatic Neoplasms / therapy. Pleural Neoplasms / secondary. Pleural Neoplasms / therapy. Positron-Emission Tomography. Radiotherapy, Adjuvant. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19705248.001).
  • [ISSN] 1437-7772
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


93. Schindera ST, Soher BJ, Delong DM, Dale BM, Merkle EM: Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology; 2008 Jul;248(1):140-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
  • PURPOSE: To determine the effect of two pairs of echo times (TEs) for in-phase (IP) and opposed-phase (OP) 3.0-T magnetic resonance (MR) imaging on (a) quantitative analysis prospectively in a phantom study and (b) diagnostic accuracy retrospectively in a clinical study of adrenal tumors, with use of various reference standards in the clinical study.
  • Single-breath-hold IP and OP 3.0-T MR images in 21 patients (14 women, seven men; mean age, 63 years) with 23 adrenal tumors (16 adenomas, six metastases, one adrenocortical carcinoma) were reviewed.
  • However, with scheme B, no overlap in the adrenal gland SI-to-liver SI ratio between adenomas and nonadenomas was seen (P < .05).
  • With scheme B, no overlap in adrenal gland SI index-to-liver SI index ratio between adenomas and nonadenomas was seen (P < .05).
  • CONCLUSION: This initial experience indicates SI index is the most reliable parameter for characterization of adrenal tumors with 3.0-T MR imaging when obtaining OP echo before IP echo.
  • [MeSH-major] Adenoma / diagnosis. Adrenal Gland Neoplasms / diagnosis. Echo-Planar Imaging / methods. Image Enhancement / methods. Image Interpretation, Computer-Assisted / methods

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) RSNA, 2008.
  • (PMID = 18566172.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Naya Y, Suzuki H, Komiya A, Nagata M, Tobe T, Ueda T, Ichikawa T, Igarashi T, Yamaguchi K, Ito H: Laparoscopic adrenalectomy in patients with large adrenal tumors. Int J Urol; 2005 Feb;12(2):134-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy in patients with large adrenal tumors.
  • OBJECTIVES: The maximum size of adrenal tumors that should be removed by laparoscopic adrenalectomy is controversial.
  • We conducted a retrospective comparison of the results of laparoscopic adrenalectomy between patients with adrenal tumors > or =6 cm ('large tumors') and patients with adrenal tumors <6 cm ('small tumors').
  • METHODS: The participants in the study were 16 patients with large tumors and 111 patients with small tumors.
  • Of the 16 patients with large tumors, five had Cushing's syndrome, four had pheochromocytomas, six had a non-functional tumor and one had malignant lymphoma.
  • Adrenal tumors were confirmed by hormonal assays, biochemical tests and computed tomography.
  • Of the 16 large tumors, five tumors were on the right and 11 were on the left.
  • RESULTS: We found no significant differences in general demographic parameters between patients with large and small tumors.
  • The mean duration of surgery was not significantly different between two groups. (large tumors, 210 min; small tumors,175 min).
  • The mean volume of blood loss was 212 mL for large tumors and 30 mL for small tumors (P < 0.001, significant difference).
  • Tumor size (> or =7.5 cm) was an independent predictor of a longer operation and greater blood loss in large tumors.
  • CONCLUSIONS: Laparoscopic adrenalectomy for large tumors was safe and minimally invasive.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15733106.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


95. Tsuru N, Suzuki K, Ushiyama T, Ozono S: Laparoscopic adrenalectomy for large adrenal tumors. J Endourol; 2005 Jun;19(5):537-40
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy for large adrenal tumors.
  • BACKGROUND AND PURPOSE: Laparoscopic adrenalectomy remains a controversial procedure for large tumors.
  • PATIENTS AND METHODS: A total of 178 patients underwent laparoscopic adrenalectomy, of whom 29 patients had large (>or =5 cm) tumors.
  • Their mean age was 47.9 years (range 21-72 years), and the mean tumor size was 6.5 cm (range 5.0-11.0 cm).
  • They were compared with patients whose adrenal tumors were <5 cm.
  • RESULTS: The large-tumor group had a mean operating time of 176 +/- 48 minutes (range 84-278 minutes) and a mean blood loss of 136.6 mL (range 10-800 mL) and required a mean of 1.8 days before starting oral intake.
  • The length of recovery was significantly longer in the large-tumor group (5.4 v 4.5 days; P < 0.05), but this was not true if a patient with a 23-day postoperative stay is excluded.
  • The overall incidence of complications was 12% in the large-tumor group, which was not significantly different from that in the control group (P > 0.05).
  • CONCLUSIONS: The operating time, blood loss, and incidence of complications after laparoscopic adrenalectomy did not differ between the patients with large and small adrenal tumors, indicating that experienced surgeons can safely and effectively use laparoscopy for larger tumors.
  • However, it is necessary to consider carefully whether laparoscopic surgery is indicated for tumors that show infiltration on preoperative imaging or for patients who have undergone previous upper-retroperitoneal surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15989440.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Turányi E, Dezso K, Paku S, Nagy P: DLK is a novel immunohistochemical marker for adrenal gland tumors. Virchows Arch; 2009 Sep;455(3):295-9
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DLK is a novel immunohistochemical marker for adrenal gland tumors.
  • Delta-like protein (DLK) is expressed in fetal and adult adrenal glands.
  • We have investigated if this expression is maintained in adrenal gland-derived tumors.
  • All the studied 37 cortical tumors, including five carcinomas, stained positively as well as the 13 examined pheochromocytomas.
  • Thus, DLK is a very sensitive marker for adrenal tumors of cortical and medullary origin.
  • Renal cell carcinomas, presenting the major differential diagnostic problem for cortical tumors, were all negative, as well as melanomas, which are similar to high portion of adrenocortical tumors that react with melan-A.
  • Therefore, this novel immunohistochemical marker seems useful for the identification of adrenocortical tumors while it has limited value for the distinction of pheochromocytomas from diagnostically related neuroendocrine tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / chemistry. Biomarkers, Tumor / analysis. Intercellular Signaling Peptides and Proteins / analysis. Membrane Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19685073.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DLK1 protein, human; 0 / Intercellular Signaling Peptides and Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / delta protein
  •  go-up   go-down


97. Hiéronimus S, Bernard JL, Chevallier P, Chevallier A, Chyderiotis G, Fenichel P, Landraud L: Adrenal tuberculosis after a pheochromocytoma: a misleading tumoral presentation. Ann Endocrinol (Paris); 2007 Jun;68(2-3):191-5
Hazardous Substances Data Bank. HYDROCORTISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal tuberculosis after a pheochromocytoma: a misleading tumoral presentation.
  • Adrenal gland involvement could account for 6% of active tuberculosis.
  • The diagnosis of this extrapulmonary form of tuberculosis is difficult, especially when presenting as unilateral adrenal tumor.
  • This report describes an unusual case of adrenal tuberculosis presenting as a tumor occurring shortly after surgical removal of an adrenal pheochromocytoma located in the opposite gland, in a 63-year-old woman with a previous history of breast cancer.
  • A pheochromocytoma in the left adrenal was diagnosed and resected.
  • One year later, while physical examination and biological parameters were unremarkable, an enhanced adrenal computed tomography (CT) scan showed a right adrenal mass mimicking the CT features of the resected pheochromocytoma.
  • A peripheral tissular rim delineating a central hypodensity characterized this tumor.
  • Definitive diagnosis was provided by culture of tissue sample, which resulted in the identification of Mycobacterium tuberculosis.
  • In an era of tuberculosis resurgence, this unusual case underscores the necessity of keeping in mind adrenal tuberculosis as a possible differential diagnosis in adrenal tumors of uncertainty nature.
  • It stresses the importance of culture of biopsy tumor, whenever feasible, to avoid unnecessary operations.
  • [MeSH-major] Adrenal Gland Diseases / complications. Adrenal Gland Diseases / diagnosis. Adrenal Gland Neoplasms / complications. Adrenal Gland Neoplasms / diagnosis. Pheochromocytoma / complications. Pheochromocytoma / diagnosis. Tuberculosis / complications. Tuberculosis / diagnosis
  • [MeSH-minor] Adrenergic alpha-Antagonists / administration & dosage. Adrenergic alpha-Antagonists / therapeutic use. Anti-Inflammatory Agents / therapeutic use. Antineoplastic Agents, Hormonal / adverse effects. Antitubercular Agents / therapeutic use. Breast Neoplasms / pathology. Diagnosis, Differential. Female. Fludrocortisone / therapeutic use. Humans. Hydrocortisone / therapeutic use. Interferon-gamma / metabolism. Labetalol / administration & dosage. Labetalol / therapeutic use. Laparoscopy. Magnetic Resonance Imaging. Middle Aged. Tamoxifen / adverse effects. Tomography, X-Ray Computed


98. Zografos GN, Vasiliadis G, Farfaras AN, Aggeli C, Digalakis M: Laparoscopic surgery for malignant adrenal tumors. JSLS; 2009 Apr-Jun;13(2):196-202
MedlinePlus Health Information. consumer health - Pheochromocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic surgery for malignant adrenal tumors.
  • Advances in imaging have improved early detection of primary and metastatic adrenal tumors.
  • The laparoscopic approach, the gold standard for benign adrenal diseases, is controversial for malignant adrenal tumors.
  • A prospective randomized study of the role of laparoscopic surgery in adrenal cancer is not feasible because of the rarity of the disease.
  • A review of the literature demonstrates the safety and efficacy of laparoscopic adrenalectomy for solitary adrenal tumors.
  • In primary adrenal malignancies, the laparoscopic approach should be considered cautiously, only when it can achieve complete tumor resection with an intact adrenal capsule.
  • Conversion to an open procedure should be an early decision, prior to tumor morcellation or fracture of the tumor capsule.
  • Patients who have local invasion, tumors that are too large, or require organ resection require an open procedure.

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 2006 Jun;91(6):2027-37 [16551738.001]
  • [Cites] Hormones (Athens). 2006 Jan-Mar;5(1):52-6 [16728385.001]
  • [Cites] J Surg Oncol. 2006 Aug 1;94(2):128-31 [16847903.001]
  • [Cites] Clin Nucl Med. 2006 Dec;31(12):822-5 [17117086.001]
  • [Cites] Eur J Endocrinol. 2007 Apr;156(4):483-7 [17389464.001]
  • [Cites] J Endocrinol Invest. 2007 Mar;30(3):200-4 [17505152.001]
  • [Cites] Surg Endosc. 2007 Aug;21(8):1373-6 [17356945.001]
  • [Cites] JSLS. 2007 Apr-Jun;11(2):261-5 [17761094.001]
  • [Cites] JSLS. 2007 Oct-Dec;11(4):487-92 [18237516.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2008 Feb;18(1):42-6 [18266573.001]
  • [Cites] Surg Clin North Am. 2000 Oct;80(5):1427-41 [11059712.001]
  • [Cites] World J Surg. 2001 Jul;25(7):914-26 [11572033.001]
  • [Cites] Surgery. 2001 Dec;130(6):1072-7 [11742341.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2001 Dec;11(6):409-13 [11814133.001]
  • [Cites] Arch Surg. 2002 Aug;137(8):948-51; discussion 952-3 [12146996.001]
  • [Cites] World J Surg. 2002 Aug;26(8):1043-7 [12045859.001]
  • [Cites] Ann Chir. 2002 Sep;127(7):512-9 [12404845.001]
  • [Cites] Biomed Pharmacother. 2002;56 Suppl 1:132s-138s [12487269.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Apr;13(2):106-10 [12709616.001]
  • [Cites] Surg Oncol. 2003 Aug;12(2):105-23 [12946482.001]
  • [Cites] Ann Surg Oncol. 2003 Dec;10(10):1191-6 [14654476.001]
  • [Cites] Minerva Chir. 2004 Feb;59(1):1-5 [15111826.001]
  • [Cites] Surg Clin North Am. 2004 Jun;84(3):755-74 [15145233.001]
  • [Cites] Am J Surg. 2004 Jun;187(6):705-12 [15191862.001]
  • [Cites] Am Surg. 2004 Aug;70(8):668-74 [15328798.001]
  • [Cites] N Engl J Med. 1984 Nov 15;311(20):1298-303 [6149463.001]
  • [Cites] J Surg Oncol. 1992 Aug;50(4):258-62 [1640712.001]
  • [Cites] N Engl J Med. 1992 Oct 1;327(14):1033 [1387700.001]
  • [Cites] J Endocrinol Invest. 1992 Oct;15(9):631-42 [1479146.001]
  • [Cites] J Endocrinol Invest. 1992 Oct;15(9):643-9 [1479147.001]
  • [Cites] Gynecol Oncol. 1993 Jul;50(1):15-9 [8349158.001]
  • [Cites] Intern Med. 1993 Oct;32(10):789-94 [8012074.001]
  • [Cites] J Surg Oncol. 1995 Mar;58(3):149-54 [7898109.001]
  • [Cites] Eur J Nucl Med. 1995 Apr;22(4):315-21 [7607261.001]
  • [Cites] Am J Hypertens. 1997 Apr;10(4 Pt 1):479-81 [9128218.001]
  • [Cites] J Clin Endocrinol Metab. 1997 May;82(5):1317-24 [9141510.001]
  • [Cites] Arch Surg. 1997 Aug;132(8):914-9 [9267279.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):238-46; discussion 246-7 [9339930.001]
  • [Cites] J Urol. 1997 Dec;158(6):2227 [9366350.001]
  • [Cites] Cancer. 1998 Jan 15;82(2):389-94 [9445197.001]
  • [Cites] Urology. 1998 Jun;51(6):920-5 [9609627.001]
  • [Cites] Surg Oncol Clin N Am. 1998 Oct;7(4):765-89 [9735133.001]
  • [Cites] Cytokine. 1998 Sep;10(9):720-8 [9770334.001]
  • [Cites] Eur J Cancer. 1998 Oct;34(11):1721-4 [9893659.001]
  • [Cites] Semin Surg Oncol. 1999 Jun;16(4):293-306 [10332775.001]
  • [Cites] BJU Int. 2004 Nov;94(7):1026-9 [15541121.001]
  • [Cites] Lancet Oncol. 2004 Dec;5(12):718-26 [15581542.001]
  • [Cites] J Urol. 2005 Feb;173(2):519-25 [15643237.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1176-9 [15490056.001]
  • [Cites] Curr Cancer Drug Targets. 2005 Mar;5(2):139-48 [15810878.001]
  • [Cites] Am J Surg. 2005 Apr;189(4):405-11 [15820450.001]
  • [Cites] Eur J Cardiothorac Surg. 2005 May;27(5):753-6 [15848309.001]
  • [Cites] Horm Metab Res. 2005 Dec;37(12):717-21 [16372223.001]
  • [Cites] World J Surg. 2006 May;30(5):893-8 [16680605.001]
  • [Cites] Semin Nucl Med. 2006 Jul;36(3):228-47 [16762613.001]
  • (PMID = 19660215.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 63
  • [Other-IDs] NLM/ PMC3015945
  •  go-up   go-down


99. McHugh K: Renal and adrenal tumours in children. Cancer Imaging; 2007;7:41-51
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal and adrenal tumours in children.
  • The differential diagnosis of renal and supra-renal masses firstly depends on the age of the child.
  • Neuroblastoma (NBL) may be seen antenatally or in the newborn period; this tumour has a good prognosis unlike NBL seen in older children (particularly NBL in those aged 2-4 years).
  • Benign renal masses predominate in early infancy but beyond the first year of life Wilms' tumour is the most common renal malignancy, until adolescence when renal cell carcinoma has similar or increased frequency as children get older.
  • Adrenal adenomas and carcinomas also occur in childhood; these tumours are indistinguishable on imaging but criteria for the diagnosis of adrenal carcinoma include size larger than 5 cm, a tendency to invade the inferior vena cava and to metastasise.
  • The most topical dilemmas in the radiological assessment of renal and adrenal tumours are presented.
  • Topics covered include a proposed revision to the staging of NBL, the problems inherent in distinguishing nephrogenic rests from Wilms' tumour and the current recently altered approach regarding small lung nodules in children with Wilms' tumour.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Diagnostic Imaging / methods. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Age of Onset. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / epidemiology. Child. Child, Preschool. Diagnosis, Differential. Ganglioneuroblastoma / diagnosis. Ganglioneuroblastoma / epidemiology. Ganglioneuroblastoma / pathology. Humans. Infant. Infant, Newborn. Lung Neoplasms / radiography. Lung Neoplasms / secondary. Magnetic Resonance Imaging. Mass Screening. Neoplasm Staging. Neuroblastoma / diagnosis. Neuroblastoma / epidemiology. Neuroblastoma / pathology. Neuroblastoma / secondary. Neuroblastoma / therapy. Pheochromocytoma / diagnosis. Pheochromocytoma / epidemiology. Positron-Emission Tomography. Tomography, X-Ray Computed. Wilms Tumor / diagnosis. Wilms Tumor / epidemiology. Wilms Tumor / pathology. Wilms Tumor / therapy

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1999 Oct 14;341(16):1165-73 [10519894.001]
  • [Cites] Curr Probl Cancer. 2005 Sep-Oct;29(5):221-60 [16216623.001]
  • [Cites] Urology. 2005 Dec;66(6):1296-300 [16360460.001]
  • [Cites] J Pediatr Endocrinol Metab. 2006 May;19(5):749-56 [16789642.001]
  • [Cites] Eur J Radiol. 2001 Feb;37(2):72-8 [11223474.001]
  • [Cites] Eur Radiol. 2001;11(10):2071-81 [11702143.001]
  • [Cites] Radiographics. 2002 Jul-Aug;22(4):911-34 [12110723.001]
  • [Cites] Med Pediatr Oncol. 2003 Jan;40(1):18-22 [12426681.001]
  • [Cites] Radiographics. 2003 Jan-Feb;23(1):29-43 [12533638.001]
  • [Cites] Am J Surg Pathol. 2003 Jul;27(7):1005-7 [12826894.001]
  • [Cites] Eur J Pediatr. 2003 Sep;162(9):623-8 [12811553.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):838-45 [14990639.001]
  • [Cites] Pediatr Surg Int. 2004 Jan;20(1):27-32 [14689211.001]
  • [Cites] J Pediatr Surg. 2004 May;39(5):759-63 [15137014.001]
  • [Cites] J Nucl Med. 2004 Jul;45(7):1172-88 [15235064.001]
  • [Cites] Cancer. 2004 Oct 1;101(7):1575-83 [15378495.001]
  • [Cites] Cancer. 1987 Jun 1;59(11):1853-9 [3567848.001]
  • [Cites] J Clin Oncol. 1997 Mar;15(3):1171-82 [9060561.001]
  • [Cites] Acta Radiol. 1999 Sep;40(5):534-42 [10485244.001]
  • (PMID = 17339140.001).
  • [ISSN] 1470-7330
  • [Journal-full-title] Cancer imaging : the official publication of the International Cancer Imaging Society
  • [ISO-abbreviation] Cancer Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 19
  • [Other-IDs] NLM/ PMC1828369
  •  go-up   go-down


100. Morimoto R, Satoh F, Murakami O, Hirose T, Totsune K, Imai Y, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues. J Endocrinol; 2008 Jul;198(1):175-83
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues.
  • AM is expressed in various tumors including adrenocortical tumors and modulates tumor growth.
  • The AM2/IMD expression has not been studied, however, in adrenal tumors.
  • The expression of AM2/IMD and AM was therefore studied in human adrenal tumors and attached non-neoplastic adrenal tissues by immunocytochemistry (ICC).
  • ICC showed that AM2/IMD and AM immunoreactivities were localized in adrenocortical tumors and pheochromocytomas.
  • RIA detected IR-AM2/IMD in adrenal tumors (0.414+/-0.12 to 0.786+/-0.27 pmol/g wet weight, mean+/-S.E.M.) and attached adrenal tissues (0.397+/-0.052 pmol/g wet weight).
  • RT-PCR showed expression of AM2/IMD, CRLR, and RAMP1, RAMP2, and RAMP3 mRNA in tissues of adrenal tumors and attached adrenal glands.
  • In conclusion, AM2/IMD is expressed in human adrenal tumors and attached non-neoplastic adrenal tissues and may play (patho-)physiological roles in normal and neoplastic adrenals as an autocrine/paracrine regulator.
  • [MeSH-major] Adrenal Gland Neoplasms / chemistry. Adrenal Glands / chemistry. Peptide Hormones / analysis

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18460550.001).
  • [ISSN] 1479-6805
  • [Journal-full-title] The Journal of endocrinology
  • [ISO-abbreviation] J. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / ADM2 protein, human; 0 / Peptide Hormones; 0 / RNA, Messenger
  •  go-up   go-down






Advertisement